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Abstract
Radiation-induced genetic instability has been observed in survivors of
irradiated cancerous and normal cells in vitro and in vivo and has been
determined in different forms, such as delayed cell death, chromosomal
aberration or mutation. A well-defined and characterized normal human-
diploid AG1522 fibroblast cell line was used to study giant-nucleated cell
(GCs) formation as the ultimate endpoint of this research. The average
nuclear cross-sectional areas of the AG1522 cells were measured in µm2.
The doubling time required by the AG1522 cells to divide was measured.
The potential toxicity of the Hoechst dye at a working concentration on
the live AG1522 cells was assessed. The yield of giant cells was deter-
mined at 7, 14 and 21 days after exposure to equivalent clinical doses of
0.2, 1 or 2 Gy of X-ray or proton irradiation. Significant differences were
found to exist between X-ray or proton irradiation when compared with
sham-irradiated control populations. The frequency of GCs induced by
X-rays was also compared to those formed in proton irradiated cultures.
The results confirm that 1 Gy X-rays are shown to induce higher rates
of mitotically arrested GCs, increasing continually over time up to 21
days post-irradiation. The yield of GCs was significantly greater (∼10%)
compared to those formed in proton populations (∼2%) 21 days post-
irradiation. The GCs can undergo a prolonged mitotic arrest that signifi-
cantly increases the length of cell cycle. The arrest of GCs at the mitotic
phase for longer periods of time might be indicative of a strategy for cell
survival, as it increases the time available for DNA repair and enables
an alternative route to division for the cells. However, the reduction in
their formation 21 days after both types of radiation might favour GCs
formation, ultimately contributing to carcinogenesis or cancer therapy re-
sistance. The X-ray experiments revealed a dose-dependent increase in
the GCs up to 14 days after irradiation. Although the proton irradiation
was less efficient in producing GCs, their frequency was elevated in a dose-
dependent manner 7 days after irradiation, with persistent expression of
nuclear deformity as an indicator of genetic instability. In addition to the
quantification of the GCs, the proliferation of a small fraction of giant
cells formed at 14 days after 0.2 Gy of proton irradiation was observed
to divide into asymmetrical, normal-sized daughter cells. These results
might have important implications in evaluating risk estimates, or could
act as a potential radioprotective assay for a dose-limiting parameter for
delayed effects in healthy tissues during radiation therapy treatment.
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Chapter 1
Introduction
1.1 Background
Radiotherapy (RT) is the use of radiation to kill cancer cells. The fundamental aim
behind radiotherapy always remains the same, to control the volume of cancer and
preserve health and the quality of life. To achieve this goal, the applications of con-
ventional radiotherapy have been developed, and treatments for cancer using heavy
charged particles are being used, including intensity modulated radiotherapy (IMRT)
and proton therapy. However, increasing precision on any geometrical relationship
between the therapeutic dose and targeted tumour is consequently identified over
a larger volume of adjacent normal tissues that are irradiated to substantially low-
doses of radiation. These low-doses are thought to be responsible for increasing the
potential risk of a secondary cancer induction [1–3].
The estimation of the effect of ionising radiation at low-doses was extrapolated
from the high doses obtained throughout different epidemiological studies. This eval-
uation was not sufficient to show the relative cellular responses at low-doses of ra-
diations. Therefore, many groups have approached cellular-based experiments using
various endpoints to measure this effect on cells in vitro and in vivo following exposure
to different qualities of radiation [4].
After that, the molecular biology has shifted the emphasis of radiation biology
research towards different cellular characterisations, such as delayed cell death and
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chromosomal aberration, particularly at low-doses of radiation. As a result, the criti-
cal molecular phenomenon of genomic instability (GI) has been discovered and consid-
ered later as a hallmark of cancer [5, 6]. Moreover, it was suggested that small doses
of radiation are capable of inducing a variety of delayed and non-targeted effects
including bystanders (BE) and hyperradiosensitivity (HRS), in vitro and in vivo.
In the context of radiation protection, these results need to be considered dur-
ing radiotherapy treatment. However, the acceptance of this discovery, was delayed
because of the conflict with DNA direct-hit theory [7].
Over the past 50 years, various studies have demonstrated that ionising radiation
can induce several diverse responses. This includes the formation of giant-nucleated
cells (GCs) in the progeny of irradiated mammalian cells, either in vitro or in vivo
[8, 9].
According to the observations of Rondanelli et al. [10], GCs can even be induced
after an X-irradiation dose of as low as 0.12 Gy. Radiation-induced GCs have been
referred to as alterations in the morphological features of the cellular system. These
alterations may lead to substantial changes in biochemical function, such as a distur-
bance in the regulatory proteins for the cell cycle (e.g. p53), deficiency in the DNA
synthesis or genetic damage appearing at the time of attempted cell division [11,12].
As such, it can bypass the senescence and cell death stages and result in the devel-
opment of highly unstable cells usually containing one or more giant nucleus.
The nuclei of giant cells usually contain multiple complements of chromosomes
and, thus are considered as polyploidy cells. Alteration to one or more chromosomes
might develop aneuploidy, which is one of the leading causes of cancer [13]. These
giant cells can contain a single nucleus (mono-nucleated), double nuclei (bi-nucleated)
or three or more nuclei (multi-nucleated) [14, 15]. These GCs are considered to be
metabolically active for a long time, as has been evident partially from their ability
to adhere firmly to the dish surface and re-attach when sub-cultured, in a similar way
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to normal cells [8]. Eventually, a fraction of these GCs could successfully divide to
form para-diploid populations, which may alter the efficacy of radiation therapy or
contribute to development of a second cancer risk [16].
While the formation of GCs is frequently observed in cancerous human cells [17], it
has also been found in normal human cells and predominately in irradiated fibroblast
cells [11, 18]. Thus, fibroblasts are considered a suitable in vitro model in evaluating
the delayed effects of radiation therapy [19].
1.2 Aim and objectives
This thesis aims to assess the delayed effect of ionising radiation in terms of giant-
nucleated cell (GC) formation as an endpoint in progeny of healthy cells in vitro. The
thesis focuses on study of the development of GCs in a well defined and characterised
normal human-diploid AG1522 fibroblast cell line1 following irradiation with 250 kV
photon therapy at the Royal Surrey County Hospital (RSCH), Guildford, UK [19–22].
This project was also designed to examine the persistent induction of GCs with
proton therapy to determine whether radiation quality is a contributing factor com-
pared to X rays. Therefore, the Vertical beamline at the Ion Beam Centre (IBC) in
the University of Surrey, Guildford, UK, with accelerated 3 MeV protons was also
utilised to assess this response.
One of the objectives was to measure the nuclear cross-sectional area of giant-
nucleated cell using a cell-recognition MATLAB software code that is originally writ-
ten and upgraded (up to version 4.1) to practically quantify GCs with proliferating
normal cells in the same field.
1Personal communication: Professor Munira Kadhim (Professor in Radiation Biology, Depart-
ment of Biological and Medical Science, Faculty of Health and Life Sciences, Oxford Brookes Uni-
versity, Oxford, UK).
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Finally, this thesis aims to investigate the fate of randomly selective giant cells
formed after 0.2, 1 and 2 Gy X ray and proton irradiations. For this aim the potential
cytotoxicity of Hoechst 33258, the live cell DNA stain, at the concentration used for
live-cell fluorescence microscopy was assessed.
1.3 Approach and innovation
The work approached and described in this thesis is related to the analysis of delayed
persistence formation of giant-nucleated cells at various interval times after exposure
to 0.2, 1 and 2 Gy of X-ray irradiations. The viability and potential fate of a selective
fraction of GCs formed in progeny of each dose point were also identified.
Initially, several procedures and experiments were performed. Initially, the thresh-
old criterion to select GCs was determined based on the literature [10] during fixed-cell
microscopy studies using fluorescence microscopic imaging system with DAPI, which
is used to label the DNA for fixed cells. A MATLAB code was written and devel-
oped2 to recognise GCs and measure their nuclear cross-sectional areas. The code
was applied in a false threshold (black and white) on the digital images captured dur-
ing fixed- and live-cell fluorescence microscopy experiments to eliminate variations of
fluorescence intensity.
For the live cell DNA stain, the Hoechst 33258 was used to label the AG1522
nuclei [23] and its toxicity was examined at various concentrations. The cytotoxicity of
the stain at the continuous working concentration used in this work was also assessed.
The growth curves for the AG1522 cells were obtained and the average doubling time
(Td) that is required for the live-cell microscopy was determined.
In this project for the first time, the vertical beamline facility at Ion Beam Centre,
University of Surrey, Guildford, UK was used to evaluate delayed formation of GCs in
2Collaborative supervisor: Dr Michael Merchant (Lecturer in Proton therapy Physics, Institute
of Cancer Sciences, Faculty of Medical Human Sciences, University of Manchester, Manchester,
UK).
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AG1522 cells irradiated with equivalent clinical doses, comparing results with those
obtained for X-ray irradiation experiments.
Proton therapy is an emerging radiotherapy modality that provides a better con-
formal dose distribution to the targeted volume of tumour compared to photon ther-
apy treatment. This minimizes doses of radiation received by normal tissues in the
vicinity of tumour. However, little data of clinical trials is available on the effects of
low-doses of protons (heavier ions) [24].
1.4 Thesis outline
The current chapter briefly provides the reader with an overview of the project-related
background and the research aims and objectives which described this approach and
innovation. The work undertaken highlights the potential medical applications in
evaluating risk estimates for delayed effects in healthy tissues throughout the course
of radiation therapy treatment with a particular attention applied to GCs.
Chapter two contains the literature review which introduces the reader to relevant
biological and physical principles including the biophysical properties of ionising ra-
diation. It also describes the rare but serious side-effects of ionising radiation during
the course of radiotherapy treatment, focusing on GCs, which includes the underlying
mechanism of their formation and potential proliferation in vitro.
Chapter three, presents the cell line, laboratory materials, experimental proce-
dures, equipments and mathematical models used in this thesis. It also describes the
relevant cell-recognition MATLAB code used to assess the in vitro development of
giant-nucleated cell after exposure to X-ray or proton irradiation.
Chapter four, discusses the experimental results achieved against the aims spec-
ified earlier in this chapter and compares them with the published data available in
the literature.
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Chapter five, summarises the main findings and indicates their potential impli-
cations for studies aimed in determining the risk of delayed effects when applying
radiotherapy treatments. This chapter is followed by a list of publications and scien-
tific contributions resulting from this PhD research project.
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Chapter 2
Literature Review
2.1 Introduction
Normal mammalian cells usually contain a diploid complement (2 sets) of chromo-
somes that enables conservative genetic integrity (genotype) during cell replication
and recombination. The morphological and functional features (phenotype) of cells
remain stable over many generations of cell replication. Conversely, any cellular phe-
notypic variations, such as enlargement of the area of cell nucleus following exposure
to genotoxic (e.g. ionising radiation) or non-genotoxic injury will be an indicative of
genetic instability within the cellular system [25].
In this chapter, the biological mechanisms behind these morphological changes
will be discussed. The focus will be particularly on the incidence and consequences
of giant-nucleated cells (GCs) in biological systems following exposure to different
qualities of radiation. The growing amount of evidence which indicates that GCs
could grow, differentiate and either die or divide to another giant- or normal-sized
cells will be reviewed.
2.2 Cell biology
Normal cell (eukaryote) is the building block of living things. Life depends on its
ability to conserve, retrieve and transmit the genetic information to its descendants
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at cell division from one generation to the next through the reproductive cells. This
information consists of the required instructions for making proteins, which serve the
cell to perform most of its functions.
This hereditary information is carried on threadlike structures within every eu-
karyotic cell nucleus, known as chromosomes. These chromosomes consist of both
proteins and deoxyribonucleic acid (DNA), the double helical molecules where the
hereditary information is encoded and stored as genes.
2.2.1 DNA structure
The structure of the DNA arises from the chemical features of its double poly-
nucleotides strands. Each nucleotide is composed of sugar (deoxyribose) attached
to a single phosphate group and a genetic subunit that might be one of the four
bases: Adenine (A), Cytosine (C), Guanine (G) or Thymine (T) (Figure 2.1).
Figure 2.1: Structure of DNA double helix. The DNA is composed of four genetic
nucleotides bases Adenine (A), Cytosine (C), Guanine (G) or Thymine (T) linked
together per DNA strand with a sugar-phosphate backbone. The two DNA strands
are held together by hydrogen bonds between their bases [26].
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These nucleotides are linked together in a chain through the sugar and phosphate
groups making the backbones for each strand of the DNA. The two strands are held
together internally by hydrogen bonding between their different nucleotides bases.
2.2.2 Cell cycle
The rate and progression of the cell division are controlled by several factors including
the stability and maintenance of the DNA. Thus, most of the time and efforts are spent
on growing the mass of proteins and organelles that are required for transmission of
the DNA-containing genetic materials accurately throughout the cell cycle [27]. The
cell cycle divides into two main sensitive phases: the synthesis (S-phase) and mitosis
(M-phase) phases with two additional gap phases, G1-phase and G2-phase (Figure
2.2). The G1, S and G2 together are called interphase where the cell growth occurs.
During G1-phase, the cell contents are replicated and the environmental conditions
are monitored to allow suitable preparations for the cell prior proceeding to S-phase.
Figure 2.2: A typical euokarotic cell cycle that is divided into four phases: G1, S, G2
and M. Figure originally published in [26].
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In the presence of DNA damage, the cell enters into the resting state (G0-gap)
and remains there before resuming to the cell cycle until the repair is completed.
After passing this point, the cell is then allowed to proceed to the S-phase. It is
important to emphasise that the S-phase is the only part of the cell division where
the DNA replication occurs. By its end, the two copies of chromosomes are produced
and remained connected together at their centromeres. In a growing mammalian cell,
the S-phase typically lasts for about a third of the total time of the cell cycle of
approximately 24 hours.
DNA damage can occur as a result of spontaneous errors in DNA replication or
due to exposure to ionising radiation or cytotoxic chemicals. This damage can abort
or delay the cell cycle and prevents the cell to enter M-phase. Therefore, the following
G2-phase is especially important in this respect where the duplicated chromosomes
are checked for errors before attempting to segregate them by the end of M-phase,
which soon follows.
In mitosis, the cell undergoes a series of continuous and sequential stages that
contribute to nuclear (karyokinesis) and cytoplasmic (cytokinesis) divisions. These
stages are: prophase, pro-metaphase, metaphase, anaphase and telophase.
It begins when the cell enters the prophase as the two identical chromatids (sister
chromatids) and their mitotic spindles are formed. Rapidly at pro-metaphase and just
preceding metaphase, the nuclear envelope breaks down and the sister chromatids
make their first attachment to the mitotic spindles. During metaphase, the sister
chromatids are firmly attached with the mitotic spindles and aligned in the centre
of the cell. The cell carries on to anaphase as sister chromatids are synchronously
separated to form two daughter chromosomes, each is pulled toward the spindle pole.
In quick succession, telophase occurs as the chromosomes are packed into separate
nuclei making the end of karyokinesis, and mitosis complete. Finally, cytokinesis
finishes the cell cycle by dividing the cell to create two daughters, each with one
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nucleus. In normal eukaryotic cells, M-phase is occupying only about an hour of the
cell division compared to the interphase. However, this small fraction of cell cycle
represents the ultimate decision that is made for the cell fate and its appearance [26].
2.3 Biological effects of ionising radiation
In the context of molecular radiobiology, the nuclear DNA damage can occur as a
result of exposure to ionising radiation. This radiation is commonly used for ra-
diotherapy treatment of patients with cancer. Radiotherapy is considered the most
effective treatment for the long-term control of many tumours. It can be used in-
dependently as a curative treatment to damage tumour cells or as a palliative in
combination with surgery or chemotherapy to relieve tumour related-symptoms, pro-
vide good therapeutic results and improve the quality of patients’ lives.
2.3.1 Biophysical properties of ionising radiation
All conventional photon therapy machines are capable of producing ionising radiation
with sufficient energy, thus causing DNA damage and cell death to several types of
tumours [28].
Most of the photon energy, however, deposits in the first few centimetres of the
healthy cells at the beam entrance followed by an exponential decrease in their dose
depth. Thus, photon beams are more dependent on their interactions with the other
molecules in the cell prior to reaching and damaging the DNA. Therefore, hadron
therapy treatment has been developed which uses heavy charged particles, such as
protons to deliver the maximum dose of radiation precisely to the DNA targets in the
treatment volume (Figure 2.3) [29].
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Figure 2.3: The figure shows the various dose depth of photons, protons and carbon
ion beams. The photons build-up their effect at the beam entrance with an exponen-
tial decrease of the dose as the depth increases. In contrast, both proton and carbon
ions spare their energy until the end of ions track forming what is known as the Bragg
peak, where the maximum dose of their energy is deposited. Adapted from [29].
Thus, proton beams have been proposed for clinical use in treating cancer patients
to achieve a high control of the tumour volume [30]. Protons as well as heavy charged
particles are characterised with an increased depth dose profile, allowing a better dose
distribution, high relative biological effectiveness (RBE) with an increase of the dose
deposition at the end of the particle range and minimal side effects to the healthy
cells in the vicinity [31]. Increasing the RBE in the tumour volume with minimal
effects on the surrounding healthy tissues is one of the main advantages of using
proton therapy over conventional treatments in tumour therapy. Although the dose
conformation of other charged particles, such as carbons is steeper than for protons,
the nuclear fragmentation processes can produce a small secondary dose which result
in affecting healthy tissues beyond the tumour volume.
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2.3.2 Relative biological effectiveness
In radiobiology, RBE is defined as the ratio of the dose of the reference radiation,
which is usually X- or γ-rays, to the dose of the particle radiation under investigation
to produce the same biological effect [28]. It is expressed as follows:
RBE =
dose of reference radiation
dose of particle radiation
(2.1)
In radiation protection, RBE is represented by the radiation weighting factor (WR)
(Table 2.1) [32]. The International Commission on Radiological Protection (ICRP)
recommended a WR value equal to 2 for protons. However, this value was not based
on absolute RBE values or enough radiobiological data [33].
Table 2.1: Recommended radiation weighting factors (WR) for different qualities of
radiation [33].
Radiation quality Radiation weighting factor (WR)
Photons, all energies, (e.g. X-rays or γ-rays) 1
Protons, (proposed before to be 5) 2
α-particles 20
The National Council on Radiation Protection and measurements (NCRP) dis-
agreed with ICRP assuming that even at the largest depth including the interactions
with nuclear DNA target, the typical value for protons corresponds to the WR is 2 [32].
Although this value is proposed for the cosmic ray proton interactions, however, is in
a good accord with the clinical value used for proton therapy [34].
The RBE is a fundamental radiobiological parameter that is used for comparing
the dose levels of different qualities of radiation causing the same effect for a certain
endpoint. It is not constant but even variable for particles with identical atomic
composition. It depends on several factors, including radiation dose, dose rate and
cell type [32,34].
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2.3.3 Linear energy transfer
The most important physical parameter, which the RBE strongly correlates with is
the linear energy transfer (LET). LET is the term that is defined by the International
Commission of Radiological Units (ICRU) to describe the average energy deposition
(E ) by a charged particle in traversing a unit path of a medium (x ) [35]. It is expressed
according to the following formula:
LET (keV/µm) =
dE
dx
(2.2)
Based on the LET values, the quality of different types of radiation can be deter-
mined and classified as high- and low-LET radiations (Table 2.2) [36]. The 250 keV
X-rays with an LET value of ∼ 2 keV/µm are described as low-LET radiation.
Table 2.2: Linear energy transfer (LET) values for different qualities of ionising radi-
ation [36].
Radiation quality LET (keV/µm)
Cobalt-60, γ-rays 0.2
250-kV, x-rays 2.0
2.5-MeV, α-particles 166
10-MeV, protons 4.7
150-MeV, protons 0.5
14-MeV, neutrons (Track average equal to 12) 100
In contrast, α particles which have an LET of ∼ 166 keV/µm are recognised as
high-LET radiation. The LET values also describe the ionisation density of high- and
low-LET radiations as densely and sparsely ionising radiation, respectively. Typically,
with an LET of ∼ 100 keV/µm, the radiation reaches the maximum of its relative
biological effectiveness. This greatly increases the chance of the double strands breaks
(DSBs) formation with a single track as the average separation between the ionisation
events is ∼ 2nm, which is almost the diameter of the DNA double strands (Figure
2.4).
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Figure 2.4: The diagram illustrates the maximum RBE for cell killing for a radiation
with an LET of 100 keV/µm. The average separation between ionisation events for
such a radiation is almost equal to the diameter of the DNA double strands (∼ 2 nm
or 20 A˚). This radiation quality can cause sufficient DSBs, resulting in cell death or
carcinogenesis [36].
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2.3.4 Fraction of surviving cells
The cell survival data can be interpreted by fitting them through the mathematical
models, such as Linear-Quadratic model (LQ) [37,38]. Thus, the radiobiological mech-
anisms and behaviour of different cell types can be explained in response to ionising
radiation or chemotherapy agents. The LQ Model is routinely used in radiotherapy
treatments to describe the responses of tumour cells to the prescribed radiation dose
which is given to patients during the treatment course [39]. The formula for the LQ
model is [28]:
SF = exp(-αD - βD2) (2.3)
where α/β (Gy) values determine the bending shape of the survival curve on a loga-
rithmic scale. The αD (Gy−1) describes the linear radiation damage which is equal to
the quadratic contribution of radiation to the damage βD2 (Gy−2) [28]. As the LET
increases, the cell survival decreased and their curves become straighter and steeper
as observed on the T1g kidney human cell cultures following exposure to various
qualities of densely ionising radiation, such as α-particles.
The shoulder shape indicates the efficiency of radiation quality and deficiency of
damage repair in response to ionising radiation. The reduction in the cell survivals
indicates a higher ratio of cell killing with a probability of an inappropriate DNA
damage repair (DDR) in response to ionising radiation (Figure 2.5) [40,41].
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Figure 2.5: An example of a typical survival curve for cells irradiated in vitro and
plotted on a logarithmic scale using the LQ model [28].
The higher efficiency of high RBE-LET radiations with the reduction of the sur-
viving values can be explained by the deposition of an adequate amount of energy
of radiation and production of complex and less repairable DNA damage. This com-
plexity increases when the damage exceeds the tumour volume to the cells in close
vicinity. Thus, the probability to induce sublethal damage in the surrounding healthy
tissues elevates with increasing radiation dose. This view is supported by the results
obtained with cell types containing genomic instability or bystander effects [42].
The LQ model gives a reasonable description of cellular response to ionising ra-
diation at high- and low-dose regions (i.e. 1-6 Gy). However, the effect of ionising
radiation below 1 Gy has been underestimated and this leads to deviations from the
linear-quadratic dose relationship. Below this dose, the cells show other effect in
response to low-doses of ionising radiation know as hyperradiosensitivty (HRS) that
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results in an increase in cell killing. The HRS is usually followed by an increase in cell
survival. The transition from sensitive to resistant response results in the existence
of an increased radio-resistance (IRR) region which is thought to be triggered by an
increase in the level of DDR system to overcome the excessive DNA DSBs occurred
within cells in the HRS region [43, 44]. Both HRS and IRR responses are important
considerations in the context of radiotherapy. They have been recognised in many
cancerous and normal cell cultures after exposure to different qualities of ionising
radiation using various biological endpoints [45, 46]. Therefore, modifications have
been applied to the LQ model to introduce what is called, Induced Repair (IndRep)
model which takes into account the dose-response relationship relevant to these pro-
cess at the HRS and IRR regions (Figure 2.6). The IndRep formula is expressed as
follows [28]:
SF = exp(-αrD(1 + (αs/αr - 1)exp(-D/Dc)) - βD
2) (2.4)
where αs describes the low-dose HRS region which is distinct from that of αr the
conventional high-dose response. The D is the dose and Dc value (Dc  D) describes
the transition change in the survival response from the HRS to IRR. The β value
represents the resistant populations (negligible at low-dose of radiation).
18
Figure 2.6: Typical cell survival curve shows the hyperradiosensitivity (HRS) phe-
nomenon for cells irradiated in tissue culture. The solid line shows the Induced Repair
(IndRep) fit for low-doses below 1 Gy. The dashed line shows the linear-quadratic
(LQ) fit applied to high-dose survival data. The derivations of αs and αr parameters
are shown in equation 2.4 [46].
Cells usually have different sensitivity to ionising radiation depending on their
phase during the cell cycle and particularly at low-LET radiation. In general, the
most sensitive phases in the cell cycle is the M- and G2-phases where the resistant
phases are S and G1 (Figure 2.7) [47,48].
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Figure 2.7: This figure shows the marked hyperradiosensitivity (HRS) for the T98G
human glioma cell line after exposure to doses between 0.05 and 5 Gy of X-irradiation
at G2-phase of the cell cycle. The survival data are fitted using both the LQ (dashed
line) and IndRep (solid line) models in vitro [48].
The HRS phenomenon represents the increase of the excessive DSBs occurs to the
DNA as observed for the T98G human glioma cell line when irradiated at the G2-
phase of the cell-cycle [48]. This damage triggers the DNA repair response, leading to
a rapid cell-cycle arrest to the cells in the IRR region [49,50]. The HRS and IRR are
less pronounced in the G1- or S-phases compared to their appearance at the G2-phase
of the cell-cycle, however, they are noticed (Figure 2.8) [48].
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Figure 2.8: Figure shows the Hyperradiosensitivity (HRS) for the T98G cell cultures
post-exposure to X-ray irradiations at G1-phase of the cell cycle. The solid line
represents the IndRep fit for low-doses below 1 Gy. The dashed line shows the LQ fit
applied to high-dose above 1 Gy [48].
As stated before, the G2-phase of the cell-cycle plays an important role in the
occurrence of HRS and IRR in response to the low-LET radiation in the region below
1 Gy as observed for the T98G cells. This phase plays also an important role in
susceptibility of cell to DNA DSBs and the induction of chromosomal aberrations
in direct proportion to the amount of energy deposited by high-LET radiation [51].
This effect has been observed in the AG1522 normal human cell cultures exposed to
0.1 Gy silicon or iron ions. The G2-phase have shown giant cells with an average
nucleus area of 242 ± 4 µm2. There is no evidence of HRS after exposure to high-
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LETs, therefore, these results confirm that the biological effects following exposure
to high-LET radiation are different from those induced by low-LET radiation [52].
2.3.5 Efficiency of high and low LET radiations
The efficiency of the RBE-LET increases with decreasing energy of radiation qualities
which have similar atomic composition, such as α-particles (Table 2.3).
Table 2.3: The table shows the LET values for α-particles with a range of energies
that are obtained from the survival curves for the T1g kidney human cells in Figure
2.9. Reproduced from [28].
Radiation quality Energy LET (keV/µm)
α-particles, (most efficient RBE) 4.0 MeV 110
α-particles 5.1 MeV 88
α-particles 26.0 MeV 25
α-particles 8.3 MeV 61
α-particles, (overkill phenomenon) 2.5 MeV 165
This concept might be right for radiation qualities with an LET values around
100 keV/µm, as observed for the T1g kidney cells following exposure to 4.0 MeV (110
keV/µm) α-particles (Figure2.9).
However, it has been noticed that the survival rate of the T1g cells irradiated with
2.5 MeV α-particles is higher than the survival populations following exposure to 4.0
MeV α-particles even though they have a higher LET value (165 keV/µm). This
indicates the lower efficiency of 2.5 MeV α-particles due to the overkill phenomenon.
The efficiency of RBE-LETs is also different for various qualities of radiation with
almost the same optimum LET value of 100 keV/µm as observed for the hamster
ovary cells following exposure to carbon, neon and argon ions (Figure 2.10) [34].
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Figure 2.9: Survival curves for the T1g kidney human cell line following exposure to
a range of doses with different high- and low-LET irradiations [28].
Figure 2.10: Survival curves for the CHO-K1, Chinese hamster ovary fibroblasts
following exposure to different energies of carbon, neon and argon ions with approxi-
mately LET values of 100 keV/µm. Adapted from [34].
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However, an excessive deposition of energy of radiation with high-LETs per cell
can result in an overkill phenomenon within the repair deficient cells. This clearly
explains the reduction of RBE efficiency for the T1g cells after the optimum LET
value of 100 keV/µm (Figure 2.11) [28].
Figure 2.11: The figure demonstrates the relative biological effectiveness (RBE) and
its dependence on the linear energy transfer (LET) for T1g kidney cells in response
to different qualities of radiation. After the high-LET value of ∼ 100 keV/µm, the
effect of RBE falls due to overkill by a very high-LETs. The peak represents the
optimum LET value. The three curves represent the the RBE in response to LET
radiations of α-particles and deuterons. The survival fraction values are calculated
for the T1g survivals (from Figure 2.9), and they are 0.8, 0.01 for α-particles and 0.1
for deuterons [28].
Although the low-LETs are considered less efficient to cause cell killing, how-
ever, it is sufficient to produce DNA damages that can lead to genomic instability or
tumourigenesis [7, 25].
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In support of this, it was estimated that exposure to 1 Gy of low-LET irradiation
is sufficient to induce ∼1000 SSBs and ∼40 DSBs to the DNA in each replicating
cell (Figure 2.12) as reported by [53–55]. Furthermore, other groups claim that even
a minor fraction of unrepaired DSBs per cell, can lead to chromosomal aberrations
instead cell death. Thus, the lethality of ionising radiation is associated significantly
with the residual DSBs, which fail to repair and transmit for several generations after
irradiation [56].
Figure 2.12: Microdosimetric structure at the scale of cell nucleus shows the ionisation
tracks after exposure to 1 Gy of low-LET X-ray (left) and high-LET α-particles
(right) [57].
The existence of the phenomenon of low dose HRS in the normal human cells could
potentially alternates the effects of radiotherapy treatments. Thus, it is suggested to
consider the HRS effect in the calculation and radiotherapy treatment planning [58].
In the context of cancer therapy, an optimal amount of energy deposition per cell
is essential by LET radiation to produce sufficient DNA DSB breaks, causing the
subsequent cell death within tumour volume. This optimum LET usually varies
between cells and is a radiation quality and cell type dependent.
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2.3.6 Targeted and non-targeted effects of radiation
Based on the target theory of radiation-induced effects, the critical target for radiation
damage in order to cause cell death or non-death related effects is the chromosomal
asset within the nuclear DNA in eukaryotic cells. This means that the damage to the
DNA occurs immediately where early effects appear shortly post exposure to ionising
radiation and all other potential biological effects can be observed in the following
generations. Thus, cancer is thought to result from a direct DNA damage, in princi-
pal, via a single track of radiation and the genetic related alterations are expected to
be clonal in the surviving irradiated cells [59]. Despite the persistence of the direct-hit
theory, there is an accumulating amount of evidence which indicates discrepancies of
some biological effects, such as delayed reproductive cell death (mitotic catastrophe),
abscopal effects with radiotherapy and non-cancerous diseases at low-dose of ionising
radiation [8,60]. The effects associated with ionising radiations can be then classified
into two distinct groups depending on the quality of radiation and targeted molecules
in the cell. These are: (1) Targeted and (2) Non-targeted effects of ionising radiation.
If an adequate amount of radiation is absorbed by the cell, there is a high possibility
that the interaction will occur directly within the targeted DNA molecules. This
process represents the classical target theory and is known as direct action of ionis-
ing radiation, which results in cell death or disturbance in genetic integrity within
survivals (Figure 2.13) [36].
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Figure 2.13: Schematic diagram showing the direct and indirect effects of ionising
radiation to the DNA molecules. The diagram holds for both high- and low-LETs [36].
It is most dominant in radiations with high-LET, such as protons and α particles.
This damage has been adequately described by the Linear-quadratic model for doses
up to 6 Gy and by the Induced Repair Model for doses below 1 Gy at the HRS
and IRR region [28]. However, as the energy of radiation is deposited randomly, the
interactions may occur with other molecules, such as water, in the cell. This leads to
the breakage of their chemicals bonds and formation of broken radiolysis molecules
(free radicals). These free radicals are highly reactive and can engage in a chain of
randomly metabolic reactions, giving rise to clusters of ionisation (i.e. more than
one break). These can cause further ionisations along the track of radiation, which
in turn reach and damage the DNA molecules [53, 57]. This kind of interactions
dominantly characterises the low-LET radiations and represents the non-direct effects
of ionising radiation [36]. Non-targeted effects are characterised by cellular responses
to the damage in cells even they though they are not directly irradiated with ionising
radiation (Figure 2.14) [61].
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Figure 2.14: Diagram of the non-targeted effects for different endpoints in response
to ionising radiation. Adapted from [61].
These effects include genomic instability (GI), bystander effects (BE) including
abscopal effects and adaptive response (AR) [7]. Genomic instability is characterised
by the persistent increase in the rate of genetic alteration in response to ionising
radiation. It is most dominantly observed in the progeny of cell initially irradiated
with low-doses of radiation. Radiation-induced genomic instability has been observed
in the progeny of directly or indirectly irradiated cells to high- and low-LET radia-
tion using various endpoints, such as chromosomal aberrations, mutation and mitotic
catastrophe [42, 62–64]. It is considered as a hallmark of cancer as is thought to
involve in the process of carcinogenesis [25, 65–67].
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The bystander effect of radiation is found in cells that have not been traversed by
radiation but are bystanders to those that have exposed to radiation. The irradiated
cells emit the damage signals to the non-irradiated cells either directly by cell-to-cell
contact or via mediated factors secreted in the medium [18, 68–73]. The abscopal
effects or out-of-field effects are another possibility related to the bystanders. These
effects have been observed in vitro and in patients treated with radiotherapy [74,75].
Another non-targeted effect is a phenomenon known as Adaptive Response (AR)
which suggests that irradiating cells with priming low dose of ionising radiation may
initially be an immunoprotective mechanism for cells that are exposed later to a chal-
lenging high doses of radiation [76–78]. However, it is thought that this mechanism
might negatively stimulate proliferation and activation of fibrosis formation which
makes cells resistant to subsequent therapy [19].
2.3.7 DNA damage and repair
It is very important for genetic integrity to keep the DNA intact throughout the cell
division. There are two essential checkpoints with a robust security system to ensure
the completion of one step before the next can begin. In the late G1 stage, there is
a G1/S checkpoint, which prevents entry of the cell with damaged DNA into the cell
cycle and S-phase. The other checkpoint is based at G2/M, which prevents entry into
M-phase. These checkpoints consist of a group of proteins, such as mitotic promoting
factor (MPF) and tumour suppressor protein (p53) that scan the genome for the
presence of DNA damage. They are involved in multiple checkpoint systems which
are located at different compartments of the cell cycle. These proteins can readily
detect DNA damage and arrest or delay the progression of the cell cycle at several of
these checkpoints until DNA repair is complete. Alternatively, they may signal this
damage to the programmed cell death in order to terminate the damaged cell.
29
The type of the DNA damage, in principle, depends on the amount of ionisation
which occurs on the site of the DNA following exposure to either high- or low-LET
irradiation. The outcome of the cell is determined by the accuracy of restoration
applied to repair that damage. Single- and double-strands breaks (SSBs, DSBs) are
the main types of the DNA damages produced post exposure to ionising radiation [79].
SSBs are rapidly repaired as the complementary base of the DNA is often intact and
in place. However, the base opposite to the SSBs might also be damaged, as occurs in
complex clusters, resulting in accumulations and conversion of the SSBs to DSBs [80].
The DSBs in the DNA are a serious threat for the maintenance of genomic stability
and cell survival, which can be permanent and irreversible if not treated adequately
on time [81–84].
Therefore, several factors determine which pathway can be used to repair the
DSBs, such as the availability of undamaged homologous template. The two major
repair pathways are Homologous Recombination (HR), and Non-Homologous End-
Joining (NHEJ) [85]. The availability of the homologous template is required for the
HR process. This identical sequence as a base for repair is the sister chromatid which
is available only in S or G2 phases [86]. If the DSBs occur in other compartments of cell
cycle, such as G1-phase, then the NHEJ mechanism will take place and promptly joins
the broken ends of the DNA. This process is rapid and needs no identical sequence
base to repair the damage, however it is less accurate compared to the HR, which is
considered as an error free process [87].
The defects in checkpoints activation and failure of the DNA repair can permit
entry into M-phase even if the DSBs have not been fully repaired. In this case, the at-
tempt to undergo mitosis leads to the activation of the mitotic cell death mechanism.
However, this also serves as a trigger to encompass mitotic death, causing morpholog-
ical changes associated with the formation and accumulation of giant-nucleated cells
containing polyploidy or aneuploidy chromosome [88].
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Many genes involved in the formation of these chromosomes are altered and can
result in subsequent reproductive cell death or oncogenesis if they success to perform
cytokinesis [84].
2.4 Giant-nucleated cell formation
As briefly mentioned before, radiation-induced genomic instability increases the rate
of incidence of genetic alterations in eukaryotic cells. Thus, cells exposed to radiation
can survive, however, they might give rise to progeny which carry heritable damages
that can persist for multiple generations after exposure. This instability may provide
a driving force for progression to cancer. One of the most biological effects that occur
in response to ionising radiation is the expression of nuclear abnormalities and related
formation of giant-nucleated cells (GCs) [89].
Giant cells might contain polyploid complements (three or more sets) of chro-
mosomes and maintain the balance between chromosomes, despite changes in total
umber of chromosomes. However, one or more chromosomes could present in unequal
numbers raising a type of abnormality abnormality called aneuploidy, which is one of
the leading causes of, and is commonly observed in, cancers [13,90,91].
The enlargement of a cell nucleus results in an increase in the size of other cellular
structures. Thereby, the entire cell will be scaled accordingly to maintain the normal
ratio of cell size [92]. The formation of GCs seems to occur during the absence or
incompleteness of the mitotic phase. They usually arise by one of, or a combination
of, three different mechanisms: (a) cell fusion, (b) endoreplication process, or (c)
mitotic catastrophe (Figure 2.15) [10].
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Figure 2.15: Schematic of the potential routes to polyploidy giant-nucleated cells.
(a) Cell fusion: following incomplete cytokinesis, sister cells fuse together and enter
mitosis through the next cell cycle generation of a giant-bi-nucleated cell with diploid
nucleus (two 2N) and centromeres. Subsequently, the centromeres are duplicated
and either clustered (left) or not clustered (right) to form bipolar or multipolar cen-
tromeres, respectively. (b) Endoreplication: an alternative pathway which cells go
through an endocycle process due to a defect occurs in karyokinesis which the DNA
is replicated (tetraploid; 4N) with the centromeres in the absence of complete mito-
sis; thus, producing a giant-mono-nucleated cell. (c) Mitotic catastrophe: a cellular
adaptation to persistent mitotic arrest due to a failure of cytokinesis results in the
formation of tetraploidy giant-nucleated cell (as in part b) or a giant-binucleated cell
(as in part a) [12].
2.4.1 Mitotic catastrophe
Most of the cell cycle checkpoints are p53 dependent. Consequently, delayed response
of p53 or insufficient DNA repair at the first barrier G1/S following exposure to ionis-
ing radiation results in cells arriving to the next checkpoint G2/M, with accumulated
mutations and breaks [93,94].
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Cells having these complex lesions usually undergo a mitotic catastrophe where
they might be partially repaired but mitotically arrested, with apoptosis and mitotic
death features in common [95]. Furthermore, a prolonged mitotic arrest in response to
ionising radiation in human cells leads to an increase in the rate of DNA breaks [96].
However, if the arrested cells remain viable and their growth capacity is increased,
they might then enhance the transition from mitotic to post-mitotic stages (terminal
differentiation; fibrosis). These terminal differentiation processes can be found in
tumours following exposure to ionising radiation [97–101].
Mitotic transition has observed to occur spontaneously in stationary cultures of the
HH-8 normal human (kidney) fibroblast cell line at mitotic fibroblast (MF). They can
differentiate into different stages of mitotic and post-mitotic fibroblast (PMF) without
exposing them to radiation. Cell-type composition of MF and PMF populations is
varied at different stages of their lifespan (Figure 2.16) [102].
Further experiments have been approached using the same cells in the MF stage
at low density which irradiated with an UV radiation to demonstrate the potential
effect of non-ionising radiation in the induction of mitotic and post-mitotic fibroblast
cell-types (Figure 2.17). The results demonstrate that the UV irradiation can enhance
the mitotic transition to further irreversible stages of PMF, as reported by [102].
The mitotic differentiation was also detected in the W139 human lung fibroblast
cell strain cultures that were incubated without further subcultivations for up to
21 days in the presence of electromagnetic field (EMF) of non-ionising radiation.
After fixed interval times of incubation, the formation of PMF cells, their cell-type
frequencies and fibrosis synthesis were identified and analysed in both non-irradiated
and irradiated cell populations [103]. Differentiation patterns and fibrotic expression
of MF and PMF cells have been also observed in HH-4 normal human fibroblast cell
line cultures following exposure to different qualities of ionising radiation.
33
Figure 2.16: Representative images for the spontaneous morphological and biochem-
ical cyto-differentiation of the HH-8 human fibroblasts cell line in vitro. The images
show a cell-type composition of mitotic fibroblast (MF) and post-mitotic fibroblast
(PMF) populations at different stages of the mitotic and post-mitotic lifespan. MF
populations of stationary cultures (left) differentiate into PMF populations (right),
three weeks post incubation without exposure to geno- or non-genotoxic agents. Mag-
nification: X52 [102].
Figure 2.17: Images for the experimentally induced post-mitotic fibroblast (PMF)
populations of the HH-8 normal human fibroblast in vitro. (A) Mitotic fibroblast
(MF) at low density irradiated with an UV radiation to induce (B) post-mitotic
fibroblast (PMF) populations. The formation of PMF is detected in the irradiated
populations. Magnification: X52. [102].
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The HH-4 cells were irradiated with doses between 1-7 Gy of γ rays. At various
time points of analysis after irradiation, higher rates of mitotic differentiation and
morphological changes were detected in the progeny of confluent cell populations
(Figure 2.18) irradiated with 1 Gy compared to those formed at higher doses of γ
rays as reported by [103].
Figure 2.18: Mitotic differentiation of the quiescent HH-4 normal human fibroblast
cell line in vitro irradiated to various doses of γ rays. The image shows a typical
morphology of the potentially active and irreversible post-mitotic fibroblast (PMF)
cell-type. The black bar represents a 75 µm [103].
Similar observations were also found in differentiation and collagen synthesis stud-
ies performed on the asynchronous cultures of AG1522 normal human skin fibroblasts
post exposure to low-LET X-rays and high-LET carbon ions (Figure 2.19) [19, 104].
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Figure 2.19: An AG1522 normal human skin fibroblast cell at post-mitotic fibroblast
(PMF) stage which is induced by exposure to X-rays or carbon ions in vitro. The
image shows the potentially active cell and its capacity that represents the amount
of collagen synthesis and extracellular matrix components [104].
These results confirm that radiation-induced morphological differentiations in dif-
ferent fibroblast cell lines causing formation and accumulation of the MF and PMF
cell populations. Consequently, the production of the matrix protein, such as col-
lagen induction resulting in formation of giant-nucleated cells (GCs) corresponding
to the increase in the cellular capacity of cells following exposure to radiation doses
of different qualities of high- or low-LET radiation. [18, 105–109]. These data are
very important for interpretation of the early and late effects of ionising radiation on
tumour as well as the normal cells in the vicinity after radiotherapy treatment [104].
The differentiated MF and PMF cells usually have finite life span before they become
senescent and die. However, they are considered viable and mitotically active based
on their morphological and biochemical characteristics. Thus, these cells undergo a
prolonged mitotic arrest that significantly increases the length of cell cycle [110].
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The activity of the MF cells and their ability to proliferate gradually decrease
over time. Subsequently, the rate of terminally differentiated PMF cells increases,
particularly at higher passage numbers. It is thought to be difficult for such cells
to re-enter the cell cycle; however, they can continue undergoing additional S-phase
rounds to increase their DNA content and to become polyploidy GCs [106].
These arrested giant cells are susceptible to potential deficiency of the p53 protein
or inactivation of other checkpoint genes, which might lead to chromosomal aberration
and an increase the rate of mutation, resulting in genomic instability [111]. If these
cells fail to remain arrested at mitosis and adapt by undergoing cytokinesis, they are
then expected to produce two distinctly giant cells [112].
In the context of cancer therapy, fibrosis is a dose-limiting factor for healthy cells
and provides an estimation of late effects of radiation therapy treatment as reported
by [105]. These fibrotic changes have been observed in progeny of irradiated normal
human cells in vitro and in vivo [19].
Although earlier studies have demonstrated that ionising radiation induces an in-
crease rate of fibroblast differentiation, which can form in normal cells more frequently
than previously thought, there is a growing amount of evidence which indicates that
fibrosis is cell type-dependent and this varied between individual fibroblast cells [113].
One possible approach for cancer therapy was by a development of inhibitors that
deliberately force cells to undergo mitotic arrest causing DNA breaks and apopto-
sis then mitotic death. However, using these anti-mitotic agents are constrained
by dose-limiting toxicity irrelevant to mitosis. Furthermore, these inhibitors were
proven to have efficacy against different types of tumours but not on nontumorous
cell lines [114–116].
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Giant cells are morphologically heterogeneous with a finite lifespan as they are
mitotically inactive. However, a fraction of them has been described to live for longer
periods (mitotically active) with reproducible alterations [102, 110, 117]. This often
involves the development of micronucleation and nuclear segmentations and this in
turn manifests a phenomenon, such as mitotic restitution [118–120]. The mitotic resti-
tution assists to initiate an endo-cycle mechanism (Figure 2.20) that helps resistant
cells to overcome mitotic catastrophe and reproduce endo-polyploidy GCs [121,122].
Figure 2.20: Schematic for mitotic cycle and endocycle of mitotic catastrophe sur-
vivals. The figure reproduced from [121].
All these diverse descriptions of mitotic catastrophe, such as mitotic arrest, mitotic
death or mitotic restitution usually depend on the efficacy and activation of the
checkpoint proteins which determine the fate of cells either to proliferate or terminate
[93].
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2.4.2 Cell fusion
Cell fusion mechanism usually occurs when two adjacent cells synchronise through
their cytoplasmic membranes (exoplasmic) following exposure to ionising radiation
[13, 90, 123]. The two membranes then merge into one another; one of the two cell
membranes disappears and its nucleus is incorporated into the other cells’ membrane;
thereby, creating one giant-binucleated cell (Figure 2.21).
Figure 2.21: Photograph for liver cell fusion by phase contrast time-lapse (21x ob-
jective) 72 hours post exposure to 6 Gy of X-ray irradiation. Arrow indicates a
binucleated cell formation. Figure reproduced from [124].
Some of these cells might remain active and stimulate other surrounding cells to
join. This process was observed to occur very often between a multinucleated and
binucleated cells (Figure 2.22) when they combine instead separation and forming
a polyploidy GCs [124]. Furthermore, some authors claim that the resulting bi-
nucleated cells were also created in human diploid fibroblasts (Figure 2.23) when
irradiated with low-doses of non-ionising radiation [125].
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Figure 2.22: Photograph for Multi and binucleated liver cell fusion by phase con-
trast time-lapse (21x objective) 72 hours post exposure to 6 Gy of X-ray irradiation.
Arrows indicate the exocytoplasmic fusion between a binucleated cell (left) and a
multinucleated cell (right). Figure reproduced from [124].
Figure 2.23: Example of binucleate of human diploid fibroblast (HDF) cells created
by low dose UV-induced cytokinesis failure (abortive cell cycle). (DNA, blue). Scale
bar represents 10 µm. The figure reproduced from [125].
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In addition to the external influence, cells often undergo fusion internally as a re-
sult of viral infection [126]. The induction of such mechanism might be rare, although
it has been reported that the cell fusion can spontaneously be created in cell culture
(Figure 2.24) from senescent cells which are no longer undergoing cytokinesis [127].
Figure 2.24: A phase contrast image (40x objective) of 3T3 fibroblast cells which
spontaneously formed polyploidy GCs. Scale bar represents 50 µm. The figure re-
produced from [127].
Incompleteness of cytokinesis and mononucleated cell fusion leading to formation
multinucleated giant cells frequently occur in tumour cells, as observed in Hodgkin
lymphoma (HL) in the presence of the multinucleated ReedSternberg (RS) cells. The
detection of these giant RS cells is considered an essential stage in the diagnosis of the
HL disease. To evaluate whether mitosis is complete before the daughter cells re-fuse
to form the giant RS cell, the HL cells were genetically labelled with the fluorescent
α-tubulin (RFP-tubulin) and tracked throughout the cell division using time-lapse
microscopy (Figure 2.25).
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The phase-contrast image shows a complete cell division and production of indi-
vidual daughter cells. However, some of the daughter cells remained connected with
microtubule network until they re-fuse resulting in one giant-binucleated cell while
the remaining cells completely separate (lower images). All images were captured
from the time-lapse microscopy movie number S7 [128].
Figure 2.25: Representative phase-contrast (left) and fluorescent (right) images for
an incomplete cytokinesis and mono-nucleated cells fusion of the Hodgkin lymphoma
daughter ReedSternberg (HLRS) daughter cells. Cells were labelled with a RFP
and α-tubulin dye (right) and tracked by long-term time-lapse microscopy to confirm
that the cell fusion is the main mechanism in the formation of the HLRS giant cells.
Adapted from [128].
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In some other cell types, such as muscle cells, cell fusion is considered as an
intermediate stage in their normal development [129]. Previous studies had described
that the other route for cell fusion and binucleated or multi-nucleated formation is
through a mitotic failure or differentiations to post-mitotic [99, 130] then abortion
of cytokinesis [84, 131–136]. Based on the cell type, however, this mitotic abortion
may constitute an intermediate stage prior to the formation of mitotically active
bi-nucleated cells and viable progeny of cells.
In support for this, other groups have confirmed that the abortion of cytokinesis
and formation of giant-bi-nucleated cells is an original physiological process in selected
rat hepatocytes. Furthermore, the p53 was expressed and the cells subsequently
divided into giant-mono-nucleated descendants. These observations indicate that
the p53 was activated, however, it did not prevent the cell cycle progression and
GCs formation. An alternative explanation for these results is that the giant mono-
nucleated cells were directly produced through endo-replication cycles [137].
2.4.3 Endoreplication
The cell fusion can not be ignored as a source of polyploidy GCs as reported by
[122, 124, 138] and others (section 2.4.2). However, mitotic restitution or endo-cycles
appear to be a prerequisite for initiation of endo-replication which is the predom-
inant mechanism involved in polyploidy GCs formation [139]. Endoreplication or
endoreduplication is a mechnaism that gives rise to additional copies of DNA. It is
an indicative of terminal differentiation and a potential strategy for cell survival that
enables an alternative route for cells to the division. Endoreplication also indicates a
spontaneous developmental process that alternate the ordinary cell cycle, producing
polyploid GCs as observed in mammalian liver cells [140]. The resulting polyploid
GCs usually contain a greater chromosomal capacity which may allow them to return
to the normal cell cycle and thereby provide a survival advantage [93].
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In addition to the survival strategy, it has been suggested that polyploidization
provides a bio-dosimetric estimate of oncogenesis within heavily injured cells [18,141].
The analysis performed on most human fibroblast cells at PMF cells have con-
firmed that they are giant-mononucleated cells (i.e. with a single giant nucleus).
Thus, the increase of the DNA content of these cells is due to the endo-replication
process but not by the mitotic arrest and blockage to the cytokinesis (abortive cell
cycle). In endoreplication cell cycles, all cells initially alternate some phases of mitosis
with distinct endocycle phases including chromosomal condensation and disassemble
the nuclear envelope. [106]. Other authors, however, claim that polyploidy giant
cells might result by endomitosis, which mitosis can occur but without nuclear or
cytoplasmic divisions, giving rise to multinucleated polyploidy cells [142].
The distinctive difference between endoreplication and endomitosis is significant.
Endoreplication is an alternative normal survival mechanism, giving rise to polyploidy
GCs [140]. In contrast, endomitosis is abortive to the cell cycle and often leads
to a variety of defects in different compartments of the cell cycle, including DNA
endoduplication and failure of the cytokinesis process [143,144].
The formation of polyploidy GCs can also be pathological, for example, occurring
during cell senescence or as a response to metabolic stress as reported by [145, 146].
The proliferation of this polyploidy population remains controversial. Some authors
claim that polyploidy GCs were the result of checkpoint failure and DNA duplications
in the absence of mitosis [147]. Therefore, they have reduced cell proliferation and
prevent cells division. Other authors suggest that checkpoint activation leads to
transient delays in the progression of the cell cycle. Thus, some of the injured cells can
persist and overcome the arrest, producing polyploidy GCs [148]. For endoreplication
to happen several checkpoints must be overcome, thereby allowing unchecked DNA
synthesis. Most of the checkpoints are p53 dependent and therefore, the resulting
polyploidy cells are often characterised by the lack of p53 function.
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A growing amount of evidence indicates that this characteristic feature is often
correlated with the most resistant tumours following genotoxic injury including ion-
ising radiation [147,149–151]. Other authors have found that however, these cells are
usually delayed and might be able to proliferate either normally through the mitotic
cycles or alternatively via restitution cycles [108,122,139,152].
Giant cells are genetically unstable with chromosomal variations, which might lead
to a formation of aneuploidy following exposure to either genotoxic or non-genotoxic
carcinogens [8]. These cells have been identified as a gene mutation-independent and
contributing cause or a secondary consequence to the development of carcinogenesis
[153]. They have the ability to adapt to the presence of alterations in the total number
of chromosomes as well as to any other chromosomal defects, such as rearrangement
or deletions [154, 155]. The aneuploidy populations following polyploidy formation
are found in a variety of human tumours. The frequency of aneuploidy cells increases
with advancing stage of tumour, as reported by [156,157].
2.5 Fate of giant-nucleated cells
As stated before, individual or a combination of several mechanisms can lead to
the formation of subpopulation of giant-nucleated cells in the progeny of insulted
population. The potential fate of these resulting GCs is varied (Figure 2.26) [12].
Some of these GCs might undergo mitotic arrest and then terminate the cellular
system by apoptosis. Some of the might bypass the DDR systems control and escape
the arrest to produce aneuploidy cells, which are a contributing cause to carcinogenesis
or secondary consequence of transformation [153,155,158].
A persistent fraction of GCs might adapt to the mitotic arrest to propagate after
as polyploidy GCs (e.g. tetraploid). Alternatively, they may proceed to the cell
division to form giant nucleated daughter cells.
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The polyploidy GCs or aneuploidy cancer cells can adapt to the presence of chro-
mosomal alterations or rearrangements and proliferate in a normal manner which
provides a survival advantage to cells and enables the formation of viable giant- or a
normal-sized daughter cells [137].
Figure 2.26: Proposal fate of polyploidy giant-nucleated cells (GCs) based on the
observations in mammalian hepatocyte during normal development or in response to
injury. (a) The fate for the majority of the polyploidy GCs is mitotic death with
apoptotic features in common. (b) If the polyploidy GCs escape the mitotic arrest,
they may re-enter the cell cycle and proceed to cell division, producing aneuploidy. (c)
A cellular adaptation to the mitotic arrest by clustering centromeres which may allow
mitosis to resume and progress normally. (d) Stable polyploidy GCs (e.g. tetraploid)
with clustered centrosomes enable mitotic spindle and bipolar mitosis [12].
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Chapter 3
Materials and Methods
3.1 Introduction
In this chapter, the cell culture techniques and irradiation treatment protocols are
discussed in detail with a particular attention to the assays applied for the GCs
analysis in response to X-ray and proton radiations.
Growth curve assay was used to determine the correct plating density for measur-
ing the population doubling time (Td) that is required by cells to undergo the next
cell division. Thus, the ideal times for GCs analysis can be predicted. The GCs assay
was the essential method performed to identify GCs and determine their potential
fate. The statistical and computational analytical methods for data analysis are also
presented.
3.2 Cells and cell culture
3.2.1 Cell line
Cell culture indicates the culturing of mammalian cells in vitro. Normal human-
diploid skin fibroblast cells (AG1522) were purchased from the NIA Aging Cell Cul-
ture Repository at the Coriell Institute for Medical Research (Camden, USA).
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The cells were at passage 16 and received in a two 25 cm2 tissue culture flasks
(T25) in Eagles Minimum Essential Medium (E-MEM) supplemented with only 5%
foetal bovine serum (FBS) to slow growth during transport. The cell sheet was micro-
scopically examined for confluency, morphology of cells and contamination using an
Axiovert-40C inverted microscope (Carl Zeiss, Thornwood, US) with a 10x objective.
Images were captured using a digital compact camera (Cannon, UK) with a Univer-
sal Digital Camera Adapter (Carl Zeiss, Thornwood, US), (Figure 3.1). The culture
flasks were wiped with a disinfecting solution (70% alcohol) and placed at 37◦C in a
humidified atmosphere with 5% CO2 (incubator) overnight with the cell sheet down
(Figure 3.2). The next day, cell cultures were examined again as indicated above
and they were apparently healthy and shown a fibroblast-like morphology (Figure
3.3). The shipping medium was removed and cells were refed with ∼5 ml E-MEM
growth medium supplemented with 15% FBS and 2.0 mM L-glutamine plus 0.01%
penicillin/streptomycin (Lonza, Berkshire, UK) and incubated for another 2-3 days
until the cell culture either prepared to be subcultured or frozen for a long-term
storage [14].
Figure 3.1: Digital camera with a universal adapter (left) and inverted microscope
(right).
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Figure 3.2: Representative image for the newly received AG1522 cells in T25 flasks
placed at the incubator overnight.
Figure 3.3: Representative image for the AG1522 cells at low-density.
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3.2.2 Cell culture
After incubation, cells were approximately at 80% confluent (Figure 3.4) and ready
for subculturing and possibly freezing some for cryogenic storage (section 3.2.3).
Figure 3.4: Representative image for the AG1522 cells at log-phase.
The newly received AG1522 cells were subcultured in a sterilised laminar-flow
hood having all the required materials wiped with a 70% alcohol and placed inside
the hood. The medium was removed by aspiration using a 5 ml sterile disposable
serological plastic pipette (Fisher, Loughborough, UK). The sides and access to the
flask were washed adequately with the Dulbeccos phosphate-buffered saline (DPBS)
to inactivate the cell growth properly. Then a ∼5 ml DPBS was added to the flask for
∼5 minutes at room temperature without dislodging the cell sheet and keeping the
flask cell-side down (Sigma-Aldrich, Dorset, UK). The DPBS was replaced with ∼2
ml of 0.1% EDTA/trypsin (0.02% in DPBS (0.5 mM) Ethylene-di-amine-tetra-acetic
acid/2.5% trypsin) solution and cell cultures were incubated at 37◦C with a 5% CO2
atmosphere for 7-10 minutes (Sigma-Aldrich, Dorset, UK).
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Cells were checked under the microscope and they were all rounded and detached
from the surface of the flask (Figure 3.5). Then ∼5 ml (2-3 times the trypsin volume)
MEM growth medium were added to the trypsinized cells, gently mixed and sus-
pended before they were pipetted off into a 15 ml standard centrifugal tube (Fisher,
Loughborough, UK).
Figure 3.5: Representative image for AG1522 cells detached off the flask surface and
rounded when 0.1% EDTA/trypsin added to them for subculture.
Cells were then centrifuged at 600 rpm (round per minute) for 3 minutes. The
supernatant was poured off into a waste pot (containing 50 ml of 1% Virkon) and the
cells pellets (i.e. trypsinised cells) were resuspended in a 5 ml growth medium. A 10
µl aliquot of a cell suspension was aspirated and pipetted on a glassy slide of haemo-
cytometer for a cell count (Sigma-Aldrich, Dorset, UK). A 1 ml of cell suspension was
plated into a standard 75cm2 (T75) tissue culture flask (Fisher, Loughborough, UK)
contained ∼12-15 ml of freshly growth medium and grown for 5-7 days before being
replated for experiments.
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The subcultured flask was given the next consecutive passage number and labelled
with the cell-related details, such as cell line and passage number (Figure 3.6).
Cells were checked routinely for mycoplasma contamination. All aseptic tech-
niques and standard tissue culture protocols with these experiments were adhered to
the guidelines described in the reference [159].
Figure 3.6: Representative image for a T25 flask having the essential cells’ details.
3.2.3 Cryogenic storage and recovery
Following the subculturing process, a fraction of the remaining cells in the cell suspen-
sion were aspirated and gently distributed into sterilised plastic ampoules (cryovials).
Each of these cryovials contained a 1 ml of cell suspension, a 100 µl DMSO (Sigma-
Aldrich, Dorset, UK) and a 100 µl FBS. All cryovial stocks were gradually frozen
down at -80◦C freezer for 24 hours then subsequently transferred to the -180◦C liquid
nitrogen tank to be stored for a long storage. All stocks were labelled as described
above (Section 3.2.2) but received the original passage number (Figure 3.7).
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Figure 3.7: Representative image for cells vial having all cells’ details before the
cryogenic storage.
For cell recovery from cryogenic storage, an appropriate tissue culture flask was
prepared and supplemented with the required volume of a growth medium and in-
cubated for ∼15 minutes at 37◦C in a humidified atmosphere with 5% CO2 while
removing cells from liquid nitrogen. Then one cryovial was removed from the frozen
storage and placed immediately in a 37◦C water bath for ∼2 minutes to be defrosted
efficiently. Once completely thawed, the cryovial was disinfected with a 70% alcohol.
The cryovial contents were then very gently aspirated, plated into the flask and mi-
croscopically checked to make sure that they were distributed evenly over the flask
surface. Cells were refed with fresh media the day after recovery.
3.3 Cell irradiation and dosimetry
Cells were irradiated with broad-beam X-rays or protons. For both types of irradia-
tions, comparable culture conditions were maintained. Each X-ray or proton irradi-
ation experiment was repeated (at least) three times, independently.
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3.3.1 Irradiation with therapeutic X-ray
X-ray irradiation was performed using a Gulmay therapeutic unit at 250 kV with a
dose rate of 0.60 Gy/min at Royal Surrey County Hospital (RSCH), Guildford, UK
(see Figure 3.8).
Figure 3.8: The Gulmay therapeutic X-ray unit at Royal Surrey County Hospital,
Guildford, UK.
Cells were grown onto 6-well plates, T25 flasks and 35-mm high µ-Dishes at a
suitable density for each experiment and incubated for 7 hours prior to irradiation.
They were in the lag-phase at the time of irradiation. The cell cultures were exposed
at room temperature to single doses between 0.05 and 5 Gy of X-ray irradiation. After
irradiation, which took ∼1 hour for each experiment, the media were changed. The
cells were then kept under standard culture conditions post-irradiation incubation
before they were analysed for clonogenic or GCs assay.
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3.3.2 Irradiation with proton beam
The vertical beamline using the 2 MV Tandem accelerator at the Ion Beam Centre,
University of Surrey, Guildford, UK, was used to produce protons at energy of 3 MeV
with averaged linear energy transfer (LET) 12 keV/µm on the target (assuming cell
nuclei are more or less spherical). The characteristics of the beamline and dosimetry
details are as described by [160]. A droplet-based method was used to prepare an
appropriate cell concentration prior to proton beam irradiation. An amount of 1×104
cells/20µl droplet of a 5×105 cells/ml final concentration of cell suspension was pipet-
ted onto a defined location on a thin polypropylene film clamped between the two
sets of a custom-made stainless steel dish. The parts of the custom-made stainless
steel dish are described in Figure 3.9.
Figure 3.9: Image for the parts the polypropylene cell dish for proton beam irradiation
experiments. All parts are numbered accordingly. The remaining part is number 6
which represents the polypropylene film.
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All parts are assembled together and polypropylene foil was clamped between
the two sets of the stainless steel dish (Figure 3.10). Each dish was contained 7
droplets including the sham-irradiated control. Each droplet was individually exposed
to proton irradiation with doses equivalent to those applied for X-rays as described
earlier [161].
Figure 3.10: Shows polypropylene foil clamped between the two sets of the stainless
steel dish.
The vertical beamline end-station uses a computer controlled motorized XYZ, 3-
dimensional stage to precisely place the polypropylene cell dish over the beam nozzle
position (Figure 3.11). After the irradiation, which took ∼10-15 minutes per dish, the
cell droplets were immediately pipetted off the polypropylene dish and pipetted onto
six-well plates, T25 flasks and 35-mm high µ-Dishes per dose including the sham-
irradiated control. Cells maintained under the standard culture conditions until they
were replated for the clononogenic or GCs assay.
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Figure 3.11: The vertical beamline at the Ion Beam Centre, University of Surrey,
Guildford, UK that is used to irradiate cell in vitro with proton beam irradiation.
3.4 End-point assays
3.4.1 Growth curve assay
The growth curve test is the ideal method to determine the correct seeding density
for cells in vitro. The early exponential growth phase would be reached when a
minimum cell concentration is seeded. Therefore, a suitable doubling time can be
obtained before the cells undergo the next subculture phase [28, 159]. Cells were
grown in T75 flask at 80% confluent then subcultured into a series of 6-well plates
(5-7 plates) with cell cultures at a density of 1×104 cells/ml per well. After 24 hours,
the cells of a single six-well plate were then trypsinized with a 400µl of a 1:10 trypsin
in EDTA (Sigma-Aldrich, Dorset, UK). A 10 µl sample from the trypsiniszd cells was
aspirated and loaded underneath the haemocytometer (Sigma-Aldrich, Dorset, UK)
coverslip, for counting. The haemocytometer device used in this work is described in
Figure (3.12).
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Figure 3.12: Representative image for the Haemocytometer.
Cells were then counted at daily intervals (i.e. every 24 hours) for 5 to 7 days
until the culture reaches the subculture phase. The population doubling times of the
AG1522 cell line was calculated during the exponential growth phase of the cells using
the following equation [159]:
Td =
t× ln2
ln(Nf/Ns)
(3.1)
where Td is the doubling time for a given cell population to double after t incuba-
tion time at any unit (hours in this study). Ns is the number of cells initially seeded
and Nf is the total number of cells recovered at subculture.
The cell doubling time calculations were also checked and confirmed using the
algorithm doubling time software (version 1.0.10) provided by the reference [162].
Due to the fact that cells usually grow at different rates during their cycle as will be
shown in Chapter 4 (Table 4.1), the average doubling time required by cells to reach
subculture time (before saturation) is considered and calculated.
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Each set of experiments was performed in triplicate and the growth curves were
plotted. These calculations are important for the live-cell fluorescence microscopy ex-
periments to tracking selected giant-nucleated cells after X-ray or proton irradiation.
3.4.2 Viability assays
3.4.2.1 Trypan-Blue exclusion test
The Trypan-blue dye exclusion test was used to determine the number of viable
cells presented in a cell suspension before any experiment including treatment with
radiation (Lonza, Berkshire, UK). It is based on the principle that live cells possess
intact cell membranes that exclude Trypan, whereas dead cells do not [130, 159, 163,
164]. In this test a 100 µl aliquot of a very well mixed cell suspension was added to a
100 µl of a 0.4% Trypan solution (a dilution factor of 2) in an eppendorf tube (Fisher,
Loughborough, UK). A 10 µl aliquot of the Trypan blue-treated cell suspension was
taken and gently filled the chamber of a glass haemocytometer underneath a glass
coverslip. The inverted microscope with a 10x objective was used to focus on the
grid lines of the haemocytometer and count the live (viable; unstained) cells in four
sets of 16 squares. The average cell count of viable cells was then multiplied by 2 to
correct for the 1:1 dilution from the Trypan-blue addition and then by 104 (1ml =
1000 µl) to obtain the number of cells in ml. The percentage of viable cells was then
calculated using the following equation [159]:
Viable cells (%) =
number of viable cells per ml
total number of all cells per ml
× 100 (3.2)
3.4.2.2 MTT cell viability test
CellTiter 96 Non-Radioactive cell proliferation assay was used to check cell viability
and proliferation according to the instructions of the manufacturer (Promega, Madi-
son, UK). It is based on the cellular conversion of a tetrazolium salt component into
a formazan product [159,165,166].
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This is usually detected by using a 96-well plate reader. The test was performed
by adding a 50 µl of growth medium in each well of a 96-well plate and incubated
for 30 minutes at 37◦C in a humidified atmosphere with 5% CO2. Meanwhile, cells
were prepared to be used for the assay. Another 50 µl of cell suspension containing
∼5,000 cells was dispensed to each well except certain rows in the 96-well plate which
were left to be used as a background reference [167]. Cells were incubated for 6-8
hours to allow them to adhere to the surface of the dish. After about 7 hours, the
media were changed and each well was filled with a 100 µl of growth media and cells
left to proliferate for 48-72 hours. A 15 µl of premixed optimised dye solution was
added to each well of the 96-well plate and incubated for no more than 4 hours. After
incubation, a 100 µl of the solubilization solution (stop mix solution) was added to the
to the cells to stop the affect of the dye solution. Then the 96-plate was placed into
the plate reader (BioTek, Swindon, UK) and absorbance of viable cells was recorded
at 570 nm (Figure 3.13).
Figure 3.13: Multimode microplate reader.
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3.4.3 Clonogenic survival assay
The clonogenic cell survival assay was used to determine the ability of every cell
in the population to proliferate and grow into a colony post exposure to ionising
radiation [168]. Cells in appropriate dilutions in accordance to the different radiation
doses were plated into several sets of 6-well plates (Table 3.1). The X-ray irradiation
experiments relay on the delivery of radiation dose using the dosimetry system at
the Royal Surrey County Hospital. The methods required to calculate and deliver
prescribed doses are based on the standard measurements at the National Physical
Laboratory (NPL), Teddington, Middlesex, UK, which allows the accurate delivery of
therapeutic doses of radiation to cancer patients. The calibration measurements are
obtained at daily and weekly intervals to ensure that the output of the therapeutic
unit is accurate. However, a very minor degree of uncertainty would be expected in
the doses delivered and estimated of approximately 2%.
Table 3.1: Shows seeding density (cells/ml) for the AG1522 normal human-diploid
skin fibroblasts per data point for each dose delivered using the Gulmy therapeutic
X-ray unit at Royal Surrey County Hospital (RSCH), Guildford, Surrey, UK. The
uncertainty of the doses delivered are estimated by almost 2%. The exposure time
values were obtained from the radiotherapy monitor unit.
Cells seeded per 6-well plate X-ray dose Exposure time
(Cells/ml) (Gy) (min)
150 0 0
150 0.2 0.37
150 0.4 0.67
150 0.6 0.79
300 1 1.66
600 2 3.17
1200 3 4.77
2500 4 6.60
5000 5 7.89
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For the proton beam irradiations, the number of cells seeded in each 6-well plate
was comparable to those applied for X-ray experiments apart from exposure time of
irradiation as it was ∼ 3 times longer than X-rays to deliver the equivalent proton
dose to cell droplets before replating them into 6-well cell cultures (Table 3.2). After
irradiation treatment, cells were incubated for up to 12-14 days. Colonies were fixed
with 4% paraformaldehyde for 15 minutes and then stained with a 5% crystal violet
in DPBS (Sigma-Aldrich, Dorset, UK). Only a fraction of plated cells was retained
the capacity to produce colonies. The colonies with 50 cells or more were counted [9].
The results were obtained from at least 7 independent experiments. The cell survival
curve was generated using the Linear-Quadratic (LQ) model to describe the cellular
radiation response [28].
Table 3.2: Shows seeding density (cells/ml) for the AG1522 cells and the average dose
of the proton beam irradiation delivered to cells in droplets using the vertical broad
beamline at the Ion Beam Centre, University of Surrey, Guildford, Surrey, UK.
Cells re-plated per 6-well plate Equivalent proton dose
(cells/ml) (Gy)
150 0
150 0.23 ± 0.02
150 0.39 ± 0.01
150 0.63 ± 0.04
300 1.04 ± 0.01
600 1.95 ± 0.03
1200 2.94 ± 0.03
2500 4.34 ± 0.09
5000 5.03 ± 0.08
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Subsequently, the curves were plotted and plating efficiency (PE) and surviving
fractions (SF) were calculated using the following equations (3.3, 3.4) [169]:
PE (%) =
Number of colonies formed
Number of cells plated
× 100 (3.3)
SF =
Number of colonies formed after treatment
Number of cells plated× PE (3.4)
where PE is the ratio of the number of colonies to the number of cells seeded
and SF is the ratio of the number of colonies survived and managed to proliferate
post-irradiation.
3.4.4 Cytotoxicity assay
The cytotoxicity test was performed as a perquisite for the live-cell fluorescence mi-
croscopy experiments [23]. Therefore, the Hoechst 33258 dye ((bis-benzimide), pen-
tahydrate) was used to counterstain nuclei in living cells (Invitrogen, Paisley, UK).
Cells were plated into 6-well plates at low density and incubated at 37◦C in a humid-
ified atmosphere with 5% CO2. After 24 hours, various concentrations between 1 to
100 µg/ml of the dye were applied to the cells and incubated for 1 more hour in a dark
environment to avoid bleaching of the stain. Then the media were changed where cells
left to grow until the time they were fixed and stained for analysis by calculating the
rate of the toxic-survivals. After the survival of cells at different concentration was
assessed, the suitable averaged working concentration for the live-cell fluorescence mi-
croscopy identified accordingly. As a support for this, two further experiments were
performed to validate the criterion of low cytotoxicity on viable cells after staining
them with a single or frequent dose of the selected working concentration (3 µg/ml).
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Two different sets of 6-well plates were prepared to perform these investigations.
Both sets contained cells plated at a low density including controls and left to grow
for 24 hours. After incubation, the first set was stained with a single dose of a 3
µg/ml of Hoechst for 1 hour and then analysed as described above. In parallel, the
second set was stained at daily intervals with the same dose and following the same
protocols. Both sets of cells left to grow for 2 week before their survival values were
calculated. Each set of experiment was triplicated. The results are presented in
Chapter 4 (section 4.5).
3.4.5 Giant-nucleated cells assay
Giant-nucleated cells (GCs) assay was designed and performed by two different ways
and for three purposes: (A) to identify and quantify the GCs formed in the progeny
of X-ray and proton irradiated populations to be performed at various intervals (7,
14 and 21 days) post-incubation (fixed-cells fluorescence microscopy); (B) to measure
the nuclear cross-sectional area for both normal and giant cells per radiation dose; and
finally (C) to track selected viable GCs post-irradiation and determine their potential
fate (live-cells fluorescence microscopy).
It should be noted that the GCs analysed in each time points of 7, 14 and 21
days were a fraction of cells having different passage numbers of 18, 19 and 20,
respectively. Each of these were allowed to proliferate for about 7 days. Every 7
days, cells from each dose point including control were split into three fractions: (1)
plated and incubated for further GCs analysis; (2) fixed-cell analysis; and (3) live-cell
analysis.
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3.4.5.1 Fixed-cell fluorescence microscopy
The DNA specific-fluorescence stain DAPI (2.5 µg/ml 4,6diamidino2phenylindole;4,6-
diamidino-2-phenylindole) was used for visualisation and quantitation of the fixed
giant- and normal-nucleated cells formed in the progeny of irradiated populations
[170]. After irradiation with X-rays, cells were grown to ∼80% subculture-phase (not
confluence) on imaging 35-mm high µ-Dishes with high walls and a polymer coverslip
(ibidi GmbH, Martinsried, Germany) and T25 flasks. At 7, 14 and 21 days, post-
irradiation incubation, the µ-Dishes were rinsed in DPBS and fixed for ∼30 minutes
at room temperature in 4% paraformaldehyde (Sigma-Aldrich, Dorset, UK). They
were then washed with DPBS (three times, 5 minutes each). A 1 ml of the nuclear
staining solution 1:10 DAPI in DPBS was applied in dark for no less than ∼10 min
(ThermoFisher, Rockford, US). Finally, a 15 µl of ProLong Gold anti-fade reagent
was added to the fixed cells for long-term storage, imaging and analysis (Invitrogen,
Warrington, UK), see Figure (3.14).
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Figure 3.14: Experimental procedures for the analysis of delayed GCs. The AG1522
cells were directly plated into T25 flasks and 35-mm high µ-Dishes prior to the irra-
diation with a single dose of 0.2, 1 or 2 Gy of X-ray irradiations. After irradiation
cells were immediately incubated and maintained under standard culture conditions
for various interval times (7, 14 and 21 days) post-irradiation incubation before re-
plating for GCs analysis. The cells in the 35-mm high µ-Dishes were then fixed and
stained with DAPI for the GCs analysis. The T25 cell cultures were subcultured at
low density into another T25 and 35-mm high µ-Dishes for further GCs analysis. The
data were obtained at each dose point including controls for each time point in three
separate experiments.
Similar protocol was used for AG1522 cells after irradiation with proton beam
irradiations but with using the polypropylene dishes following the cell-droplet method
to plate cells prior irradiations (Figure 3.15). The protocol was used for each dose
point (i.e. control, 0.2, 1 and 2 Gy). The data were obtained at each dose point
including controls for each time point in three separate experiments. The results of
GCs were compared to controls and X-ray results which are obtained in this thesis.
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Figure 3.15: Experimental procedures for the analysis of delayed GCs. The AG1522
cells were pipetted as droplets onto a polypropylene-end bottom stainless steel dish
prior exposure to proton beam irradiations. Each droplet apart from the control
was individually irradiated with doses equivalent to those applied for the X-rays
investigations. After irradiation, the cells were immediately replated and dispensed
into T25 flasks and 35-mm high µ-Dishes per dose including the sham-irradiated
control. The cells were maintained under standard culture conditions for various
interval times (7, 14 and 21 days) post-irradiation incubation before replating for
GCs analysis. The cells in the 35-mm high µ-Dishes were then fixed and stained with
DAPI for the GCs analysis. The T25 cell cultures were subcultured at low density
into another T25 and 35-mm high µ-Dishes for further GCs analysis.
The stained µ-Dishes were filled with a 2 ml DPBS and placed on a custom made
metallic slide with a 1 cm2 window in its centre allowing the reflected microscopy
light to passthrough from underneath the µ-Dish and provides a sufficient area of the
sample to be covered and scanned. The metallic slide is supported with a specifically
designed plastic dish-holder that adequately fit on the microscopy stage with a sized-
µ-Dish area in the centre to immobilise the sample during scan, (Figure 3.16).
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Figure 3.16: Representative image for the custom-made metallic slid with the plastic
holder (left) that designed for the GCs analysis. The image for the 40x immersion
objective (right) show the proper position of the objective for scanning the µ-Dish.
The µ-Dishes were scanned using a Nikon fluorescence microscope (NIS-Element
AR, ver. 4.10, Tokyo, Japan) with 40x immersion objective. The produced digital
images were analysed using the cell-recognition MATLAB code (MATLAB-R2015a,
code ver. 1.2) to obtain the measurements of nuclear cross-sectional area for both nor-
mal and giant-nucleated cells (see section 3.4.5.2). The T25 flasks were subsequently
re-plated in appropriate dilutions for further GCs analysis. The same procedures
were followed every 7 days per dose per quality of radiation for three independent
experiments.
3.4.5.2 Nuclear cross-sectional area measurements
The criterion for selecting GCs was based on the measurements of the nuclear cross-
sectional area (of the order of micrometer squares; µm2). In average, these mea-
surements were obtained from the progeny of ∼1000 control cells, attached and fixed
onto µ-Dishes using the cell-recognition MATLAB code. Accordingly, the normal
cross-sectional area for the AG1522 cells was identified. Subsequently, the values of
the nuclear cross-sectional area for the progeny of cells exposed to X-rays or pro-
ton irradiation were then measured at various intervals post-irradiation. They were
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found some four-fold greater than those formed in controls and thereby identified as
GCs [10]. The average value for the nuclear area of the GCs was calculated from
three independent measurements (mean ± standard error) per dose per type of ra-
diation including sham-irradiated controls. In parallel, these values were used as a
criterion to identify GCs in the living cells for the live-cell fluorescence microscopy
experiments.
3.4.5.3 Live-cell fluorescence microscopy
For tracking the AG1522 living cells after irradiations, the Hoechst 33258 was used
safely to label their DNA and visualise their nuclear morphology adequately following
the standard conditions for staining live cells [23]. Cells were replated at a low density
of 1×104 cells/ml onto imaging 35-mm high µ-Dishes, after were treated with X-rays
or protons and incubated for 7, 14 or 21 days. After incubations, a fraction of cells
from each dose point was allowed to proliferate for ∼20 hours (Figure 3.17).
Just before they start to replicate, a 3 µg/ml (i.e. equivalent to 4.8 µM) of the
Hoechst 33258, live DNA dye, was added to the growth medium and cells stained in
a dark environment due to sensitivity of the dye. Cell were incubated for ∼1 hour at
37◦C in a humidified atmosphere with 5% CO2. Using the Nikon fluorescence micro-
scope, cells were immediately scanned and a selective number of GCs was identified
to be followed every 24 hours. Consequently, the nuclear cross-sectional area for the
scored GCs were measured using the cell-recognition MATLAB code according to the
criterion which was identified for selecting GCs as described in section (3.4.5.2). GCs
were followed every 24 hours until their fate was determined and classified accordingly.
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Figure 3.17: Experimental procedures for the analysis of live GCs. The AG1522 cells
were pipetted as seven droplets onto a polypropylene-end bottom stainless steel dish
prior exposure to proton beam irradiations. Each droplet apart from the control was
individually irradiated with doses equivalent to those applied for the X-rays. After
irradiation, the cells were immediately pipetted off and dispensed into T25 flasks
per dose including the sham-irradiated control. The cells were maintained under
standard culture conditions for 7 days post-irradiation incubation. After 7 days, a
fraction of cells replated onto a 35-mm high µ-Dishes. After about 24 hours a 3 µg/ml
of Hoechst was added to the cells and incubated for 1 hour before they analysed for
live GCs formation. Similar procedures were used to analyse GCs after X-rays but
with irradiating cells immediately in the T25 flasks instead polypropylene dish. Each
set of experiments was used three times for 0.2, 1 and 2 Gy of radiations including
controls and for various interval times (7, 14 and 21 days).
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3.4.6 Mycoplasma detection assay
The mycoplasma assay is one of the first tests which is recommended to be performed
on the newly received cells to confirm the healthy status of the cells to be used for cell
cultures. One of the most efficient and commonly used assays to detect mycoplasma
infection is the microscopic detection assay [171]. It is based on the direct DNA
fluorescent staining using either DAPI or Hoechst 33258 and both of these two dyes
were routinely used in this work. During subculturing cells, before and after cryogenic
protocols and prior any experiment, a fraction of cells was usually plated into couple
of µ-Dishes and were left to proliferate for 2-3 days. Then they were fixed in a
4% paraformaldehyde for ∼30 minutes. After fixation, cells were stained in dark
with a 1 ml of DNA staining (usually DAPI for fixed cells) for ∼10 minutes. After
the staining was removed, the dishes were filled with DPBS (2 ml per dish). The
fluorescence microscope with the 40x immersion objective was used to scan dishes
and confirm the negative appearance of mycoplasma in the cell cultures.
3.5 Data analysis
3.5.1 Statistical hypothesis testing
The two-sided independent Student t-Test was applied with critical values corre-
sponding to p<0.05 (95% confidence) as described by [172]. The t-Test was used to
compare the statistical significance formation of the GCs in the progeny of X-ray or
proton irradiated populations to those formed in the progeny of the sham-irradiated
controls. The yield of the delayed GCs formed in the progeny of X-irradiated popu-
lations were also compared to those formed in the progeny of the proton irradiated
populations at the significance level of 5%. Using the Origin software (OriginLab-
2016 Graphing and Analysis), histogram plots were constructed accordingly and error
bars were calculated as the standard errors of the means.
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All statistical analysis were performed on the fixed-cells at designated intervals
post exposure to either X-ray or proton irradiation.
3.5.2 Linear-Quadratic Model
The Linear-Quadratic (LQ) model was used to fit the obtained cells survival values
post exposure to X-ray or proton irradiation using the equation (2.3) in Chapter two.
The components of cell killing that are proportional to the dose (linear contribution
to the damage) and square of the dose (quadratic contribution to the damage) are α
(Gy−1) and β (Gy−2) values, respectively [28,38].
3.5.3 Induced-Repair Model
At low-doses below 1 Gy of radiation (i.e. ≤ 0.2 Gy), most of mammalian cells have
shown a hyperradiosensitivity (HRS) which is frequently followed by an Increased
radioresistance (IRR) phenomenon [43]. The region of HRS is thought to be formed
by an excessive induction of DNA DSBs, which consequently led to a hyper-activation
of the DNA repair mechanisms [173]. The presence of such phenomena results in a
modification to the LQ model to include the out-of-fit dose points. Thus, the LQ
model was modified to develop a model called Induced-Repair (IndRep) model. This
model was used to plot the dose points presented in the HRS and IRR regions using
the equation (2.4) in the previous chapter.
3.5.4 Fluorescence image microscopy
The fluorescence microscope with the 40x immersion objective (NIS-Element AR, ver.
4.10) was used to scan the µ-Dishes for fixed or live microscopy experiments (Figure
3.18).
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Figure 3.18: Representative image for the fluorescence microscopy system used to
scan the AG1522 µ-Dishes for GCs analysis following exposure to X-ray or proton
irradiation.
The fixed cells were scanned in DPBS in dark at weekly intervals. In contrast, the
living cells were scanned at daily intervals and with µ-Dishes filled with a suitable
volume of growth media. Herein, the exposed media were immediately replaced and
cells incubated at 37◦C in a humidified atmosphere with 5% CO2 until the next visit.
The parameters and settings of the microscope were adjusted and fixed throughout
the scanning process to eliminate variations of fluorescence intensity. Taking into
account the magnification used, the digital images (∼100 images containing ∼1000
cells per dish) were produced in pixels. Then all the obtained values were calibrated
using the cell-recognition MATLAB code (MATLAB-R2015a; R2016a, code ver. 1.2)
to have the values converted to µm2.
3.5.5 Cell-recognition MATLAB code
The cell-recognition MATLAB code was used to identify and quantify the GCs and
aid to obtain the measurements of the nuclear cross-sectional area for both normal
and giant cells in µm2 (Figure 3.19).
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Figure 3.19: Shows the cell-recognition MATLAB code ver. 1.2 used to identify and
quantify giant- and normal-nucleated cells.
The obtained images were uploaded to the code. The criterion value to identify
the GCs with other related parameters was also specified allowing the code to identify
all the GCs accordingly. As a support to the fluorescence intensity, a false threshold
(black and white) was applied via MATLAB to keep the scale of intensity steady
among dishes examined for all performed experiments. Furthermore, the cells were
coloured and counted according to their nuclear cross-sectional areas. The GCs were
delineated in red, normal nuclei in purple and synchronised cells in green (multi-blobs;
MB).
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3.6 Summary
In this chapter the cell line and different assays required for GCs analysis were de-
scribed. High- and low-LET radiations were also used to compare the results pre-
sented in the following chapter. The X-ray and proton irradiations were used to
determine the efficacy on the formation of GCs corresponding to the nature of the
interaction of each quality of radiation. The fluorescence image microscopy and cell-
recognition MATLAB code were used to analyze the formation of GCs at various
intervals post-irradiations.
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Chapter 4
Results and Discussion
4.1 Introduction
To achieve the objectives of this thesis which were presented in Chapter 1, a range
of related procedures and experiments have been performed. The well-defined and
characterised normal human-diploid AG1522 fibroblast cell line was used to study
giant-nucleated cell formation as the ultimate endpoint of this research. The nuclear
cross-sectional area for the AG1522 cells was measured. The population doubling
time required by the AG1522 cells to divide was measured. The potential toxicity
of the Hoechst dye to the live AG1522 cells at the working concentration used was
assessed.
Irradiations were performed using the therapeutic X-ray unit and accelerated pro-
ton beams and the cell survivals curves were analysed. The results related to the
delayed persistence of giant-nucleated cells in the progeny of irradiated populations
have been published [174].
The final part of this chapter investigates the potential fate of selected giant-
nucleated cells following exposure to 0.2, 1 and 2 Gy of X-rays or proton radiations.
The individual GCs were localised in the dish (i.e. sample) of each dose point popu-
lations and tracked until their ultimate fate was determined.
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4.2 Cell growth analysis
As described in Chapter three, growth curve assay was performed to determine the
correct seeding density and subculture intervals for the AG1522 normal human fi-
broblast cells. Thus, the doubling time (Td) for cells can be calculated before they
undergo the next subculture phase. In brief, cells were plated into a series of 6-well
plates at a low cell density of 1×104 cells/ml per well (Figure 4.1). Thus, to maintain
exponential growth phase throughout all growth curve experiments [14, 159]. Cells
of a single 6-well plate were then harvested and counted. Routine counting has been
performed according at daily intervals (i.e. every 24 hours). By the appropriate time
at which cells have reached an adequate density (i.e. they are not confluent), they
were then harvested from last 6-well plate. All data were collected from (at least)
three independent experiments and plotted using Origin software.
In the current work, cells were routinely maintained to proliferate for 5-7 days
at a low passage number (i.e. ≤ 20) throughout all experiments. This allowed a
reduction in the difficulty in interpreting results due to differences in the formation
of giant-nucleated cells due to senescence and ageing rather than irradiation. The
development of this type of GCs is more apparent in fibroblasts at higher passage
numbers (i.e. > 20) which are incubated for more than a week and characterised
with non-dividing features in common as reported for the 3T3 fibroblast cells [127].
By using the equations (3.1), the doubling time required by the AG1522 cells
to divide was measured every twenty four hours from the first subculture (Table
4.1). The Td is very critical when tracking giant-nucleated cells using the live-cell
fluorescence microscopy to determine their fate after exposure to either X-ray or
proton irradiation.
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Figure 4.1: A descriptive growth curve for the AG1522 normal human-diploid skin
fibroblast cells. The plot illustrates the exponential growth (cell concentration;
cells/ml) of the AG1522 cells along time (days) and indicating times at which sub-
culture should be performed. The curve shows several stages during cells growth,(a)
Lag-phase: that indicates the adaptation of cells to the cultural conditions during
the first 24 hours.(b) Log-phase: that indicates the exponential growth of cells 144
hours post-incubation from the initial subculture.(c) Subculture: indicates the op-
timum growth capacity of cell concentration (80-90%) that is sufficient to proceed
to the next subculture. (d) Plateau phase: indicates the confluent density-inhibited
cultures which cells not dividing anymore synchronised in G0-G1 phases. The initial
plating density was 1×104 cells/ml per well. The curve has been performed by count-
ing cells at daily intervals (i.e. every 24 hours) then plotted by using an Origin-lab
software. Bars represent the standard errors of the mean of (at least) three indepen-
dent experiments.
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Table 4.1: Shows the resulting doubling time (Td) for the AG1522 normal human-
diploid fibroblast cells after different incubation periods. The Td was calculated
using the equation (3.1) from the data collected over 7 days of the initial seeding
concentration of 1×104 cells/ml per well.
Incubation time (h) Doubling time (h)
24 18.7
48 19.4
72 21.7
96 21.8
120 23.3
144 25.5
168 29.4
It has been reported that the AG1522 cells can have a (Td) value of 26 hours when
they are highly active and this is in agreement with the value of 25.5 hours presented
in Table (4.1) when the cell capacity was increased 6 days after incubation [175,176].
Due to the fact that cells usually grow at different rates during their cycle, the average
for the Td was considered. The Td calculated and was found to be 23 ± 1 hours which
is in a good agreement with the value of 22 ± 1 hours reported by [177,178] and also
in close accordance with the value of ∼20 hours reported by [179].
4.3 Cell survival analysis following X-ray irradia-
tions
The survival curves for the AG1522 cells were determined using the clonogenic survival
assay as described by [19]. Apart from plating and quality of radiation, however,
the cell cultures were not confluent at the time of irradiation and were immediately
incubated for 12-14 days at 37◦C post-irradiation. The cell density was selected in
response for each dose in order to obtain 50 cells or more per colony.
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Single doses between 0.2 and 5 Gy of X-ray irradiations were applied on the
AG1522 cells to measure their cloning and proliferating rate. Two weeks after irra-
diation, the clonogenic survival was assayed and data were plotted using the Linear-
Quadratic Model from the equation (2.3). Table (4.2) shows the values for the pa-
rameters in the Linear quadratic (LQ) equation fitted to the data for the AG1522
cells.
Table 4.2: Mean values and standard errors of the mean for the α and β parameters
of the AG1522 normal human-diploid fibroblast cell line obtained by fitting the cell
survival to the linear quadratic (LQ) model according the equation (2.3).
Parameters Values
mean standard error
α (Gy−1) 0.58 0.15
β (Gy−2) 0.03 0.01
To confirm the observations of the HRS and IRR effects on the AG1522 cells at
low-doses of X-ray irradiations and identify their start- and end points, the cells were
irradiated with a range of low-doses between 0.05 and 1 Gy.
Figure (4.3) shows the colonies were scored 14 days post-irradiation. Data were
fitted using the Induced Repair (IndRep) model according to the equation (2.4). On
survival fraction curve, a deviation from the LQ model can be observed (Figure 4.2).
The results suggest the occurrence of the Hyperradiosensitivity (HRS) phenomenon
at low-dose region of X-ray irradiation. The HRS is pronounced at the dose of 0.2 Gy
of X-ray irradiation, then followed by an Induced-radioresistance (IRR) phenomenon
as the dose increases up to 0.6 Gy.
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Figure 4.2: A single dose response curve for the AG1522 normal human-diploid fi-
broblast cells sorted 14 days post X-ray irradiation. The X-ray datum in the surviving
fraction means of at least three independent experiments. Bars are standard errors
of the mean. The data points are the fit of the linear quadratic LQ model. The
depth of the deviation from the LQ model indicates the hyperradiosensitivity (HRS)
phenomenon at the very low-dose region (around 0.2 Gy). The transition back to the
linear quadratic behaviour indicates the trigger of the nduced-radioresistance (IRR)
phenomenon (between 0.4-0.6 and below 1 Gy).
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Figure 4.3: Cell survival curve of AG1522 normal human diploid fibroblasts. Cells
received a range of X-ray doses between 0.05 and 5 Gy to identify the regions of
the phenomena of hyper-radio-sensitivity (HRS) and an Increased Radio-Resistance
(IRR). The existence of HRS and IRR are found in the region between 0.05-0.4 Gy
and between 0.5-0.9 Gy, respectively. The curve shows the fitting of cell survivals to
the Induced Repair (IndRep) model. The bars represent mean ± standard error of
at least five independent experiments.
The AG1522 cells show a moderate enhanced cell killing (which indicates an HRS
effect) below around 0.2 compared to the primary results, which agreed with the data
observed for the HRS on other cell lines as reported by [44]. Table (4.3) shows the
values for the parameters in the IndRep equation fitted to the data for the AG1522
cells in Figure (4.3).
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Table 4.3: Mean values and standard errors of the mean for the parameters of the
AG1522 normal human-diploid fibroblast cell line obtained by fitting the cell survival
to the Induced-Repair (IndRep) model.
Parameters Values
mean standard error
αr (Gy
−1) 0.51 0.03
αs (Gy
−1) 1.62 0.87
β (Gy−2) 0.03 0.01
dc (Gy) 0.20 0.12
In particular, the HRS was detected at the dose of 0.05 Gy. Its existence indicates
an activation of repair to the DNA damage at low-doses following exposure to X ray
irradiation as reported by others [180]. The DNA damage repair process increases up
to 0.4 Gy because many events are required to overcome the HRS effect. Moreover,
the accumulated DNA damage which is followed by a slight rise in cell survival at 0.4
Gy suggests the IRR model. Such responses were observed on human cancer cell lines
as reported by [181–183]. The IRR phenomenon was observed as a flatter response in
the range between 0.5-0.9 Gy, which determines the actual trend of the IRR region
(right after the dose point of 0.4 Gy).
The persistence of the HRS effect can contribute to increase the amount of unre-
paired DNA DSB breaks which leads to enhanced lethality by cell killing or chromo-
somal aberrations instead cell death [184]. The cell survival response at low-dose and
the observations of the HRS in the later experiments shows a change in sensitivity
than those found in the primary results.
One of the possibilities to explain this discrepancy is that most of the cells were
at G2-phase at the time of survival analysis where the manifestation of the HRS was
most dominant due to the activation of the G2/M checkpoint as reported by [48].
The other possible explanation could be due to the absence of arrest of cells that
allows transition from G2-phase to mitosis, which is an essential process involved in
the formation of HRS [49,50].
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At doses higher than 0.5 Gy, the HRS decreases gradually with increasing radiation
doses and the IRR was then triggered in the presence of a transition to the linear
quadratic behaviour. These results suggest that using the LQ might not describe the
cell survival curves for the AG1522 cells at doses below 1 Gy of X-ray irradiations
correctly as reported for other mammalian cell lines [183,185].
The existence of HRS model suggests that exposure to several single low-doses of
radiation could be more effective than higher doses in terms of reducing cell survival
and producing adequate DNA damage which trigger the radioprotective mechanisms
(DDR systems). Moreover, it has been proposed to use the HRS phenomenon clin-
ically to deliver radiotherapy as a hyperfractionated dose each of 0.1-0.2 Gy [186].
This phenomenon was validated in studies designed to use skin as a model of normal
human tissue and exposed to a fractionated dose of 0.2 Gy of X-ray irradiation (a
total dose of 7.2 Gy with a 4-hour interval period) for six times per day [187].
However, the dose of 0.2 Gy reflects also the risks to some organs of examinations
involving medical diagnostic radiography and fluoroscopy as reported in the reference
[188]. In addition, the survival results reported here are also a good motivation
to consider this dose point for further investigation using the giant-nucleated cell
endpoint. Thus, it was thought the manifestation of HRS at low-doses of radiation
would be an indication of absence of arrested cells (i.e. GCs) as hypothesised by [49].
4.4 Cell survival analysis following proton beam
irradiations
The AG1522 cells were directly exposed to a 3 MeV beam of protons. Figure (4.4)
shows the survival of density-inhibited AG1522 cells as a function of mean absorbed
dose between 0.2 and 5 Gy for proton beam irradiations. The survival results obtained
were fitted using the Linear-Quadratic (LQ) Model.
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Figure 4.4: Cell survival curve of AG1522 cells. Cells received proton beam irradia-
tions. Each data point of survival curve represent the mean ± standard error of at
least three independent experiments.
The downward bending of the curve indicates that proton irradiations enhanced
the mortality with a significant dose-dependent decrease in the survival fraction. The
curve presents a linear shape for the majority of the dose points, leading to a linear
model with a minimal exception to the 0.4, 0.6 and 5 Gy. The 0.4 and 0.6 doses falls
within the low-dose region and their behaviour possibly reflect the occurrence of the
IRR phenomenon. The distribution of average doses reflects the typical dose-response
relationship, which shows the pronounced ’tail’ phenomenon at the dose point of 5
Gy. Such findings have been observed for the AG1522 cells using other quality of
radiation [21]. However, the LQ model was more appropriate to describe these data
than the induced-repair model.
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The overall decrease in the surviving fraction can be linked to both apoptotic
cell death and mitotic arrest similar to that observed by others for proton beam
irradiations using different cell lines [189,190].
Table 4.4 shows the values for the parameters in the LQ equation fitted to the
data for the AG1522 cells following exposure to proton beam irradiations.
Table 4.4: Mean values and standard errors of the mean for the α and β parameters
of the AG1522 cell obtained by fitting the cell survival to the linear quadratic (LQ)
model following exposure to proton beam irradiations.
Parameters Values
mean standard error
α (Gy−1) 0.62 0.03
β (Gy−2) 0.02 0.01
Figure 4.5 shows the results from the AG1522 cells that were exposed to proton
beams and compared to data from clonogenic experiments performed with 250 kVp
X-rays. The plot does not show a clear evidence of an HRS in the low-dose region
(around 0.2 Gy) related to proton beam energy whereas such response was more pro-
nounced with X-rays. The absence of the HRS is frequently common in cell cultures
following exposure to high-LET radiations in vitro, such as protons. Moreover, the
manifestation of the IRR around the dose of 0.4 Gy of protons might be indicative of
the existence of HRS incorporated in the clustered DNA breaks which may be have
occurred below the lowest dose used in the experiments reported in this thesis (i.e.
0.2 Gy). This interpretation would be reasonable if the IRR was triggered below the
0.2 Gy of proton beam irradiations as hypothesised by [191]. The lack or absence of
the HRS at the low-dose region could be associated with micronuclei formation and
mitotic arrest as reported by others [192].
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Figure 4.5: Comparison of surviving fraction for the AG1522 normal human skin
fibroblast cells obtained after exposure to X rays or protons. Black symbols represent
250 keV X rays and blue symbols are 3 MeV protons.
These reports are in a good agreement with the results obtained during the fluores-
cence microscopy experiments in terms of micronuclei formation and giant-nucleated
cell fragmentations following exposure to 0.2 Gy of protons (section 4.6). The HRS
and IRR phenomena were not prominent in the AG1522 cells following irradiation
with 3 MeV protons (∼12 keV/µm) as following 250 keV X rays (∼2 keV/µm) in their
initial survival curve. The AG1522 cells exhibit less shoulder in their X ray survival
response. This means that they have a small α/β ratio which reflects the effect of
their morphological structure because they have thin nuclei compared to other cell
lines as demonstrated by [21].
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4.5 Cell toxicity analysis
The cytotoxicity of the live nuclear DNA stain using the Hoechst 33258 dye was
determined. Single doses of various concentrations between 1 and 100 µg/ml were
applied on the AG1522 normal human fibroblast cells with an incubation time of one
hour. Figure 4.6 shows the survival results of the AG1522 cells at 12-14 days following
exposure to various doses of Hoechst 33258 dye.
Figure 4.6: The survival of AG1522 cells after exposure to a single dose of various
concentrations of Hoechst 33258 dye. Cells incubated with the dye for 1 hour then
refed with fresh media and allowed to proliferated for 12-14 days to be analysed for
clonogenic survival. Bars represent the standard deviations of the means of at least
three independent experiments.
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Higher concentrations (i.e. ≥ 20 µg/ml) of Hoechst stain resulted in lower AG1522
survivals, which are not considered to be used for the live-cell fluorescence microscopy.
The cell survival curve starts to bend downwards at doses of 25 µg/ml (∼ 39 µM).
At a concentration of 50 µg/ml (∼ 77 µM) of Hoechst stain, a clear decrease in
survivals was observed where ∼ 50% of the cells were killed. The adverse effect of
Hoechst 33258 stain was observed beyond a concentration of ∼ 90 µg/ml. However,
the AG1522 survivals show steady growth at lower concentrations of Hoechst at 1
and 3 µg/ml (i.e. equivalent to 1.6-4.8 µM) at 14 days post-incubation. The viability
of cells at these two dose points falls in the range of the recommended concentration
values for staining live mammalian cells with the Hoechst 33258 (i.e. between 0.2
and 5 µg/ml) according to the instructions of the manufacturer (Invitrogen, Paisley,
UK). These results are also in excellent agreement with the working concentration
of 1.6 µM, which was used to stain DNA in living human HeLa cells as reported
by [23]. Therefore, the concentrations of 1 and 3 µg/ml were considered to be used for
live cell imaging and fluorescence microscopy in this study. During live-cell imaging
trials, the concentration of 3 µg/ml showed slightly higher intensity and more stability
(slow bleaching) in comparison to the 1 µg/ml when applied on the AG1522 controls
(Figure 4.7). These observations reflect the preferential usage of 3 µg/ml especially
when considering the limitation of exposure time and toxicity of Ultraviolet during
live-cell fluorescence microscopy [193,194].
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Figure 4.7: Representative fluorescence images captured for the AG1522 cells in con-
trol populations alive. The samples incubated with a concentration of 1 µg/ml (left)
shows lower intensity compared to those incubated with 3 µg/ml (right) of Hoechst
33258 dye. White bars represent 50 µm.
To investigate the potential cytotoxicity of the Hoechst dye at this concentra-
tion (i.e. 3 µg/ml), further experiments were performed. Cells were incubated in
growth medium with Hoechst at a concentration of 3 µg/ml continuously for ∼ 1
hour followed by changing the medium without the dye and scanned for 1-2 minutes
then incubated for 24 hours. The same technique was used continuously for five days
(Figure 4.8). The incubation with hoechst over five days period did not affect cell
viability. Moreover, the clonogenic survivals with Hoechst 33258 staining showed that
Hoechst dye was neither cytotoxic nor clastogenic at the continuous dose of 3 µg/ml.
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Figure 4.8: Steady growth in the survival of AG1522 cells after exposure to continuous
doses of 3 µg/ml of Hoechst 33258 dye at daily intervals and for 5 days. Cells allowed
to proliferate for 12-14 days then assayed for clonogenic. Error bars represent the
standard deviations of the means of three independent experiments.
Therefore, the 3 µg/ml of Hoechst 33258 was selected as the working concentration
to use for further live-cell imaging and fluorescence microscopy studies. Using this
concentration of Hoechst with the parameters of the fluorescence microscope fixed, an
adequate time to scan samples and suitable detection of giant- and normal-nucleated
cells were possible. Data were collected from three independent experiments.
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4.6 Analysis of giant-nucleated cell formation
Three measurements were carried out on the progeny of AG1522 cells after exposure to
either X-ray or proton irradiations: (1) nuclei cross-sectional areas using fluorescence
image microscopy and cell-recognition MATLAB code analysis; (2) determination the
percentage of GCs to normal cells after 0.2, 1 or 2 Gy including control at 7, 14 or
21 interval days; (3) determination the fate of selected individual GCs alive in each
dose point at each time point identified above.
4.6.1 Measurement of AG1522 nuclear cross-sectional area
The criterion for selecting GCs was based on the values of the normal nuclear cross-
sectional area for the AG1522 normal human cells in µm2. As described earlier, cells
were plated on imaging 35-mm high µ-Dishes at low density and allowed to prolif-
erate for 5-7 days before they were prepared for analysis. After fixing cells in 4%
paraformaldehyde and labelling them with DAPI, the DNA-stain, they were then
scanned using the fluorescence image microscopy. Taking into account the magni-
fication used (40x immersion objective) during the scan, the digital images (∼ 100
images containing ∼ 1000 cells, per experiment) were produced in pixels. All obtained
values were then calibrated according to the main properties of the fluorescence mi-
croscope using the cell-recognition MATLAB code to obtain the measurements of
nuclear cross-sectional area in µm2.
The normal nuclear values of ∼1000 nuclei were obtained from control populations
of (at least) ten independent experiments. The nuclear cross-sectional area of normal
cells were measured and found to be in a range from 31 to 41 µm2. The average
nuclear area for the control AG1522 cells used in this investigation was measured to
be 36.5 ± 0.3 µm2 (mean ± standard error). These values are in close accord with
the value of 42 µm2 for the nuclear area of the T1g human kidney cell line as reported
by [195].
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For giant-nucleated cell analysis, the AG1522 cells were irradiated to different
doses of 0.2, 1 or 2 Gy of X-ray or proton irradiations. After irradiation, cells were
incubated for 7 days allowing them to proliferate before they were sampled for further
subculturing and GCs analysis 14 or 21 days post-irradiation. After the first 7 days, a
fraction of each dose point was assayed for fixed- and live-cell fluorescence microscopy
for GCs analysis. Another fraction of each dose point was subcultured and plated for
the next 7 days period, as will be described on the next sections (4.6.2 and 4.6.3).
Following the same protocols with the sham-irradiated controls, the criterion value
to identify the GCs with other related parameters was also specified allowing the cell-
recognition MATLAB code to identify all the GCs within irradiated samples. The
cells were coloured and counted according to their nuclear cross-sectional areas. With
cells delineated by colours, it was possible to measure their nuclear cross-sectional
areas accordingly (Figure 4.9).
Figure 4.9: Representative image for the giant-nucleated cell (GC) identified by the
cell-recognition MATLAB code following exposure to 0.2 Gy of X-ray irradiation.
The nuclear cross-sectional area for the GC scored above has measured by 292.2 µm2.
The white bar represents 10 µm.
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The GCs were delineated in red, normal nuclei in purple and synchronised cells in
green (multi-blobs; MB). As a support to the fluorescence intensity, a false threshold
(black and white) was applied via MATLAB to keep the scale of intensity steady
among dishes examined for all performed experiments. All GCs formed in the progeny
of irradiated populations had nuclei areas some four-fold greater than those formed
in controls and were identified as GCs as reported by [10]. The average nuclear area
of the GCs was found to be 164.4 ± 1.5 µm2, with a range from 125 to 350 µm2.
These values are consistent with previous reports using either the AG1522 normal
human cells or different cell lines and correlate well with other types of radiation
[22, 196–198]. However, the variations between values for the area of cell nucleus
reported in the literature appear to depend on several parameters, such as type of cell
line [22,199], the later passage number of the cell line [200], phase of cells during cell
cycle [18,52,109,201,202], cell culture conditions and status of cells [21,203], radiation
quality [107,204] and conditions for microscopy analysis or modelling [199,205,206].
Thus, the nuclear area measured for cells given such a set of parameters should
be considered as an indicative rather than a definitive endpoint, noting that it may
not be strictly valid for cells grown under different conditions.
Based on the above measurements for the AG1522 nuclei areas, we used the cell-
recognition MATLAB code to identify the GCs that formed in the progeny of irradi-
ated and control populations.
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4.6.2 Determination of giant-nucleated cells after X-rays
The percentage of giant AG1522 cells formed in progeny of control and irradiated
populations was determined using the fixed-cell fluorescence microscopy and cell-
recognition MATLAB code.
Figure 4.10 shows fractions of GCs (%) which were formed in the progeny of
AG1522 cells that originally exposed to 0.2, 1 or 2 Gy of X-ray irradiations. Each dose
point represents the mean ± standard error of three independent experiments. The
frequent induction of GCs formed in the progeny of irradiated and control populations
was measured at 7, 14 and 21 days post X-ray irradiations (Table 4.5). The yield
of the GCs for the control populations (i.e. background) was measured by 1-2 %
and it was almost steady for all performed experiments. This result agrees with the
background formation of GCs that has been observed in Hela cells [207]. The X-
irradiated populations showed a significant increase in the formation rates of GCs
compared to controls at a significant confidence level of 95% (*p < 0.05).
At a dose of 0.2 Gy, the induction of GCs was steady with time and significantly
greater compared to those formed in controls. At 1 Gy, the yield of GCs was increased
continually at various intervals and was significantly higher than those formed in
controls and other irradiated populations (i.e. zero, 0.2 and 2 Gy populations) which
measured as about ∼ 10%, 21 days post-irradiation. The persistence formation of
GCs in the irradiated populations was in dose- and time-dependent manner following
exposure to 0.2 or 1 Gy of X-ray irradiation.
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Figure 4.10: Persistence giant-nucleated cells (GCs) formed in the progeny of AG1522
cell exposed to 0.2, 1 or 2 Gy of X-ray irradiations. The cell-recognition MATLAB
code was used to identify the GCs in fields that contained proliferating normal-
nucleated cells in the same field at 7, 14 or 21 days post-irradiation. Two-sided
independent Student t-Test with a critical value of *p ¡ 0.05 was used to compare the
formation of GCs in the irradiated populations with those formed in controls. Bars
represent standard errors of the means of three independent experiment.
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Table 4.5: Formation of giant-nucleated cells (GCs) at 7, 14 and 21 days after X-ray
irradiations; the calculated standard error is included for each data point including
control.
Giant-nucleated Cells (GCs) to normal-nucleated cells (%) *
Radiation dose (Gy) after 7 (d) after 14 (d) after 21 (d)
0 1.5 (2) 0.8 (2) 1.9 (5)
0.2 3.2 (4) 3.3 (4) 4.2 (7)
1 5.9 (6) 7.8 (6) 10.3(9)
2 7.5 (9) 9.3 (7) 2.9 (5)
For the 2 Gy populations, the formation of GCs was increased significantly to a
higher rates as a function of time compared to control and 0.2 Gy populations for up
to 14 days post-irradiation. After 21 days, the rate of analysed GCs was decreased and
measured by ∼ 2.9% which is only ∼ 1% different to the controls (∼ 1.9%), however,
still significant at the level of 5%. The possible interpretation for this reduction
could be the activation of cellular response to radiation damage at this dose point by
removal of unhealthy cell from the survivors [19]. Eventually, the dose of 2 Gy is a
therapeutic-related dose that is usually sufficient to kill most of the directly irradiated
cell as observed on the survival curves for the AG1522 cells compared to [208] or other
cell lines [209]. Eventually, the delayed cell death would be the ultimate fate for the
remaining cells that could not stand a such effect [88, 210,211].
The persistence induction of GCs in the progeny of irradiated populations is an
indicative that a fraction of arrested GCs might enter to endoreduplication cycle and
proliferate to form a progeny [121]. Alternatively, they might re-enter the mitotic cell
cycle and form progeny of diploid or polydiploid GCs and this might contribute to
carcinogenesis as reported by other authors [16,90,212,213].
4.6.3 Determination of giant-nucleated cells after protons
In parallel experiments to X-rays, the AG1522 cells were exposed to beams of accel-
erated proton ions (3 MeV).
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Cells were irradiated with averaged doses equivalent to those applied for X-ray
irradiations. A fraction of cells were sampled for GCs analysis and fluorescence image
microscopy was used to identify GCs in the progeny of control and irradiated popu-
lations at 7, 14 and 21 days post-irradiations. Figure 4.11 shows percentage of giant
cells formed in the progeny of populations irradiated with protons compared to those
formed in the sham-irradiated controls.
Figure 4.11: Persistence giant-nucleated cells (GCs) formed in the progeny of AG1522
cell exposed to 0.2, 1 or 2 Gy of proton beam irradiations. The cell-recognition MAT-
LAB code was used to identify the giant-nucleated cells in fields that contained pro-
liferating normal-nucleated cells in the same field at 7, 14 or 21 days post-irradiation.
Each dose point represents the means and standard error of the means of three inde-
pendent experiments. Two-sided independent Student t-Test with a critical value of
**p < 0.05 was used to compare the formation of GCs in the irradiated populations
with those formed in controls.
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Each dose point is the mean ± standard error of three separate experiments. The
yield of the GCs was measured at 1% in the sham-irradiated controls and was compa-
rable for all performed experiments. The plot shows a typical dose-dependent response
with a significant increase of the GCs in progeny of irradiated populations compared
to controls at 7 days post-irradiation. The rate of GCs remained significantly higher
than controls in the 0.2 and 1 Gy populations analysed 14 days post-irradiation.
However, a clear reduction in the frequency of the GCs was observed within the 2 Gy
populations with no significant difference to those formed in controls (**p < 0.05).
Moreover, the yield of GCs was measured as ∼ 2.1%, which is almost three-folds lower
than the ∼ 6.5% that measured at 7 days after irradiation (Table 4.6).
The reduction in the yield of GCs was observed to occur in the progeny of all
irradiated populations at 21 days post-irradiation with no significant difference to
controls except for the 0.2 Gy populations which was measured and to be 2.8%.
Table 4.6: Formation of giant-nucleated cells (GCs) at 7, 14 and 21 days after pro-
ton beam irradiations; the calculated standard error is included for each data point
including control.
Giant-nucleated Cells (GCs) to normal-nucleated cells (%) **
Radiation dose (Gy) after 7 (d) after 14 (d) after 21 (d)
0 0.9 (3) 1.1 (3) 1.2 (3)
0.2 3.1 (2) 3.4 (4) 2.8 (4)
1 3.9 (5) 4.5 (3) 1.9 (3)
2 6.5 (5) 2.1 (3) 1.7 (5)
4.6.4 Comparison of giant-nucleated cell formation in X-rays
versus protons
In this thesis it has been demonstrated that the persistent induction of GCs in the
progeny of irradiated AG1522 normal human-diploid fibroblasts for up to 21 days
after both X-ray and proton irradiations.
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The yield of GCs formed in the progeny of irradiated and control populations
was measured at various interval times (i.e. 7, 14, and 21 days) post-irradiation with
X-ray or proton irradiation. Figure 4.12 shows a comparison of the GCs obtained at
each dose point of 0.2, 1 and 2 Gy of X-rays and protons excluding controls at 7, 14
and 21 days post-irradiation.
Figure 4.12: Delayed persistence giant-nucleated cells (GCs) formed in the progeny
of X-ray or proton irradiated populations. The cells were irradiated with a single
radiation dose of 0.2, 1 or 2 Gy. The number of GCs was identified in ∼ 1000 cells in
each sample per dose point using the cell-recognition MATLAB code at 7, 14 and 21
days post-irradiation incubation. Each dose point represents the means and standard
error of the means of three independent experiments. Two-sided independent Student
t-Test with a critical value of ***p < 0.05 was used.
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Each dose point represents the mean ± standard error of at least three indepen-
dent experiments. The X-ray experiments revealed a dose-dependent increase of the
GCs up to 14 days after irradiation. Although the protons were less efficient in pro-
ducing GCs, yet their frequency was elevated in a dose-dependent manner 7 days after
irradiation. The dose-dependent induction for GCs in the progeny of both irradiated
populations might be an indication of the survival response after radiation damage
as reported by others [19]. The plot shows that there is no significant difference at
the level of 5% (i.e.***p < 0.05) in terms of GCs formation in the progeny of X-ray
and proton populations at 7 days post-irradiation.
At a dose of 2 Gy X-irradiation, the yield of GCs was significantly greater (∼
9%) compared to those formed in proton irradiation (∼ 2%), 14 days after irradiation
(Table 4.7). Similar results of GCs formation was observed at 21 days post-irradiation
but it was at the dose of 1 Gy of X-rays measured as five-folds higher than those
formed in protons.
Table 4.7: Delayed persistence of giant-nucleated cells (GCs) formed at 14 and 21
days after 1 and 2 Gy of X-ray or proton irradiation. The comparison between X-rays
and protons at significant level of 5% is presented and the calculated standard errors
are included for all data point.
Giant-nucleated Cells (GCs) to normal-nucleated cells (%) ***
Radiation dose (Gy) X-ray Proton Time after exposure (d)
1 10.3(9) 1.9 (3) 21
2 9.3 (7) 2.1 (3) 14
The delayed induction of GCs that measured in the progeny of 2 Gy X-irradiated
populations indicates that these giant cells might remain arrested for couple of rounds
where the DNA was duplicated before they were managed to re-enter the mitotic cell
cycle and form progeny of giant- or normal-nucleated cells [16,212]. This explanation
can still be valid for the significant induction and persistence of GCs measured at 21
days after 1 Gy of X-irradiation.
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At 21 days after 2 Gy X-ray or proton doses, the frequency of GCs was decreased
in the progeny of irradiated populations. These data supports the survival curve
results which indicates that this dose might be eventually sufficient to kill most of the
normal and giant-nucleated cells as reported elsewhere [208]. Further details about
the delayed persistence of AG1522 giant cells in the progeny of X-ray and proton
populations are available at [174].
During the process of nuclear measurements, the observation of GCs revealed that
some of these cells were rounding up or elongated which might be associated with
mitotic activity (Figure 4.13). Some of them have been seen also observed forming
mitotic bridge when they failed to perform a complete mitotic division (Figure 4.14).
Figure 4.13: Fluorescence photographs of rounded (left) and elongated (right) giant-
nucleated cells observed in the progeny of X-irradiated populations. White bar is 50
µm.
These result in a good agreement with the observations found in video time-
lapse recorded by other authors using different cell lines [88, 127, 213]. In addition,
cell deformities were observed in terms of micronuclei formation or morphological
irregularity which were increased in cell populations exposed to different doses of
X-ray or proton irradiation (Figure 4.15).
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Figure 4.14: Mitotic bridge of the AG1522 appears between two asymmetrical daugh-
ter cells. Cells were irradiated with 2 Gy of protons. The white bar is 50 µm.
Figure 4.15: Micronuclei formation and irregularity of the nucleus of the AG1522
cells following exposure to 0.2 Gy (left) and 1 Gy (right) of X-ray irradiations. The
white arrows (right image) indicate micronuclei formation (MN) next to the divided
daughter giant-nucleated cells. White bars 20 µm.
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Moreover, under detrimental and irreversible damage repair conditions such as,
exposure to high-doses of radiation, cell deformity has been observed in a form of
disintegrations. This disintegrating occurs for cells that might undergo necrosis and
usually are characterised with the residual nuclear and cellular fragments attached to
the surface after necrotic cells have been disappeared (Figure 4.16).
Figure 4.16: Fluorescence image of GC-like fragments adhering to surface of the 35-
mm high µ-Dishes observed in the progeny of cells exposed to 2 Gy X-rays at 21 days
post-irradiation. White bar is 50 µm.
Such observations have been found on giant Hela cells after exposure to far higher
radiation doses (∼12 Gy) compared to the doses used in this study [214, 215]. The
increasing rate of deformity in the irradiated populations is accounted as a loss-related
symptoms among the mitotically arrested cells that are probably failed to return to
the cell cycle as reported by [216].
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Furthermore, the rate of deformity increases as the radiation doses increase fol-
lowing a dose-dependent behaviour as suggested by [89]. The persistent expression of
abnormalities in the progeny of irradiated populations supports the hypothesis that
radiation-induced genomic instability, which might lead to different types of muta-
tions and cancers [217,218].
These results support the persistence induction of GCs that observed in the
progeny of X-ray or proton cell populations, suggesting that these irradiated pop-
ulations consist of at least a fraction of GCs undergoes mitotic arrest before they
either die or escape death and divide.
In separate experiments, there was an attempts to investigate the correlation
between increasing the radiation dose and the potential increase in the area of giant
cell nucleus. Therefore, several samples of the AG1522 cells were exposed to higher
doses (i.e. ≥ 3 Gy) of either X-ray or proton irradiations and assayed for GCs analysis.
Figure 4.17 shows a sample of giant cell produced after 4 Gy of proton irradiation.
There was an increase in the area of giant cell nucleus some three-fold greater than
those formed in populations irradiated to 0.2, 1 or 2 Gy.
The selected giant-nucleated cell was delineated in red, while normal cells around
were identified in purple. The nuclear cross-sectional area of the giant cell was mea-
sured as about 523.4 µm2, which is almost fourteen-folds greater compared to those
formed in controls. These results would be an indicative of a dose-dependent increase
in the cross-sectional areas. However, it is not the case as such dose-relation response
was not observed in the progeny of irradiated AG1522 cells following exposure to 0.2,
1 and 2 Gy of X-rays or protons.
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Figure 4.17: A representative image of a giant cell scored seven days following expo-
sure to 4 Gy proton beam irradiation. The image processed in a false threshold scale
using the cell-recognition MATLAB code. The cells were delineated post-processing,
distinguished by colour based on their nuclear area. White bar is 50 µm.
4.6.5 Live imaging analysis of giant-nucleated cells
Previous reports have described that at least some of giant-nucleated cells (GCs) (ei-
ther mono-, bi- or multi-nucleated cells) which formed in the X-irradiated populations
could proliferate and produce a progeny that might be able to divide up to several
generations. However, most of those studies have only observed the formation of GCs
following exposure to high doses (i.e. ≥ 3 Gy) of X-rays [213]. Moreover, to the
author’s knowledge there was not a study that investigated such formation of GCs
following exposure to proton beam irradiation nor following them further. Parallel
to the current X-ray experiments, the AG1522 cell cultures were irradiated to high-
and low-doses of proton beam irradiations using the vertical beam facility in the IBC,
Guildford, University of Surrey. Using the fluorescence image microscopy and the cell-
recognition MATLAB code have expanded the observations of fixed GCs to tracking
selective individual GCs alive and determine their ultimate fate post-irradiation.
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4.6.5.1 Fate of giant-nucleated cells produced by X-rays
As described before in Chapter 3 (section: 3.4.5.1) and following exposure to X-ray
irradiations, a fraction of cells in each dose point (i.e. 0.2, 1 or 2 Gy) at various time
points (i.e. 7, 14 or 21 days) was assayed for live-cell fluorescence microscopy. Briefly,
following exposure to 0.2 Gy, cells were incubated for 7 days. Then, cells were de-
tached and two samples of cells were taken to: (1) subculture and allow to proliferate
for another 7 days for the further GCs analysis, and (2) set for live-cells fluorescence
microscopy to analyse after 24 hours. One day later, the medium was changed with 1
ml of mixed medium that contains a 3 µl of Hoechst 33258 and incubated for 1 hour
at 37◦C in a humidified atmosphere of 5% CO2 in air. After incubation, the medium
changed with 2 ml of fresh medium and fluorescence image microscopy was started af-
ter locating ∼100 fields that contained GCs with proliferating normal-nucleated cells
in the same field. The GCs were selected randomly, then the medium was changed
immediately after scan and samples incubated for next visit for live cell scanning.
Following exposure to 0.2 Gy X-rays, the behaviour of a total of 13 GCs have
been determined. The nuclear cross-sectional area of each GC was determined using
the cell-recognition MATLAB code according to the specified criterion for selecting
GCs (Table 4.8). The XY values for the field of view at which GCs identified were
recorded at the initial 24 hours of observation to recognise their locations on the next
day of scanning. The fate of most of the individual GC was identified and compared
with other dose points of X-rays or proton beam irradiations. During the observation
period, all of the individual GCs were followed until they were either divide, died or
remained arrested in the cell cycle or were lost.
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Table 4.8: Fate of the giant-nucleated cells (GCs) followed in the progeny of AG1522
normal human-diploid fibroblast after exposure to 0.2 Gy of X-ray irradiation. Hor-
izontal lines represent observations at 7, 14 and 21 interval days of analysis post-
irradiation. Uncertainty of the cell-recognition MATLAB code reproducibility is es-
timated by 1%.
Giant-nucleated Nuclear cross-sectional Ultimate
cells (GCs) area (µm2) fate
1 146.0 lost
2 213.6 arrested
3 143.9 arrested
4 163.8 lost
5 126.2 arrested
6 171.8 arrested
7 149.2 lost
8 135.8 lost
9 191.3 lost
10 142.2 arrested
11 160.0 lost
12 236.8 lost
13 227.8 lost
Overall, there were 49% of the tracked GCs either dead or mitotically arrested.
The fate of the remaining 51% of GCs could not be determined because they were
lost. This loss occurs because of migration of GCs from the microscopy field and
predominance of rapidly proliferating normal-nucleated cells [219]. The studies [220]
are also consistent with the results presented in this thesis that radiation-enhanced cell
proliferation and migration at low-doses of X-ray irradiation. Although no successful
attempt was observed among the lost GCs to divide and form progeny at the time
of observation. However, the behaviour and features of some of them indicate that
they might still alive with a minimal possibility to divide and form colonies (Figure
4.18). The average cross-sectional area for the GCs that have been tracked within
populations irradiated with a dose of 0.2 Gy X-ray was measured and found to be
172 ± 11 µm2.
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Figure 4.18: Representative images for GCs number one and four captured 7 days
after exposure to 0.2 Gy of X-ray irradiation. They were appeared active during
the scan at the first 24 hours post-incubation. Both cells were lost from the field of
observation on day two of the scheduled live scan study. White bars represent 10 µm.
Following the same protocol, a fraction of 17 GCs formed in the progeny of cells
that originally irradiated with 1 Gy of X-rays could be traced to determine their
fate (Table 4.9). From the total of 17 GCs, 59% which represents the majority of
GCs were lost during 48-96 hours of scanning period. Those lost GCs might have a
potential chance to survive and perform a progeny of giant- or normal-sized daughter
cells. The remaining 41% of GCs were either died or arrested. The observations have
confirmed that none of the arrested GCs were succeed to divide even after 72 hours
post-irradiation.
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Table 4.9: Fate of the giant-nucleated cells (GCs) followed in the progeny of AG1522
normal human-diploid fibroblast after exposure to 1 Gy of X-ray irradiation. Hori-
zontal lines represent the interval times of 7, 14 and 21 days post-irradiation.
Giant-nucleated Nuclear cross-sectional Ultimate
cells (GCs) area (µm2) fate
1 171.5 lost
2 128.0 lost
3 125.3 lost
4 214.8 arrested
5 140.7 lost
6 202.1 lost
7 129.4 arrested
8 143.6 lost
9 334.7 lost
10 267.7 lost
11 213.5 arrested
12 421.1 arrested
13 194.7 arrested
14 183.7 lost
15 277.6 arrested
16 130.5 lost
17 129.5 arrested
The most enormous giant-nucleated cell during GCs analysis was observed in the
X-ray experiments was GC 12, which was measured and found to be 421.1 µm2.
It was difficult for the cell to be stimulated to re-enter the cell cycle but instead
continue undergoing internal duplications to increase its DNA content and become a
polyploidy giant-nucleated cell as observed at 48 hours of the scanning time which
agrees with the observations reported by [106]. Although this leads to transient
delays in the progression of the cell cycle as it was remained mitotically arrested for
almost 72 hours; thereafter, the rate of enlargement decreased, reaching a nuclear
cross-sectional area of 65.5 µm2 (Figure 4.19).
110
Figure 4.19: Representative fluorescence image of mitotically arrested giant-nucleated
cell following exposure to X-ray irradiation. The image shows the most giant-
nucleated cell (GC 12) that scored at the first 24 hours in the Hoechst 33258 sam-
ple which was prepared for GCs analysis 21 days after exposure to 1 Gy of X-ray
irradiation. The nuclear cross-sectional area of the cell was measured using the cell-
recognition MATLAB code and found to be 421.1 µm2. The cell remained mitotically
arrested during the observation time with an expression of gradual decrease in its
cross-sectional area. Four days later (i.e. 96 hours) of the scanning time, the cell
showed a noticeable decrease in its size which was almost seven-fold lesser than the
original size when was identified as GC. White bar represents 10 µm.
It was observed isolated from other cells with dying features in common. There
was no significant attempt to divide even when it was shrunk to almost two-folds the
cross-sectional area of normal-nucleated cell which was measured in control popula-
tions (∼36.5 µm2). However, this injured cell could persist and overcome the arrest,
producing decedents of polyploidy GCs, as suggested by [148].
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The average cross-sectional area for the total of 17 GCs irradiated with 1 Gy
of X-irradiation was 200 ± 20 µm2. The results show that none of the mitotically
arrested GCs were observed to undergo division during the observation period.
The fate of another 10 giant-nucleated cells was identified in the progeny of
AG1522 populations exposed to 2 Gy of X-irradiation was also determined (Table
4.10). Three of them were selected from the 7 days time point samples, another four
from the 14 days samples and the remaining three were selected from the last popula-
tions which were analysed 21 days post-irradiation. As expected, the majority of the
GCs represented by 60% of the total GCs selected to be followed, were either dead
or arrested without dividing. This could be as a result of an excessive deposition of
energy of radiations per cell which produces severe DNA damage. These results indi-
cate the significant effect of such dose leading to sufficient killing among the survivals
including GCs. However, 40% of them were lost and so they might escape death with
the minor X-ray survivals to form progeny of either giant- or normal-nucleated cells.
The other discrepancy to this lost might refer to the increase of migration of cells as
observed in other studies using the fibrosacroma (HT1080) cell line, when irradiated
with 2 Gy of X-ray irradiations [221].
The average cross-sectional area of the total GCs analysed after 2 Gy irradiations
was measured and found to be 181 ± 8 µm2 which is lower than the mean value that
recorded for the nuclear area of GCs formed in the progeny of cells irradiated to 1
Gy irradiation (Table 4.11).
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Table 4.10: Fate of the giant-nucleated cells (GCs) followed in the progeny of AG1522
normal human-diploid fibroblast after exposure to 2 Gy of X-ray irradiation. Hori-
zontal lines represent the interval times of 7, 14 and 21 days post-irradiation.
Giant-nucleated Nuclear cross-sectional Ultimate
cells (GCs) area (µm2) fate
1 160.3 lost
2 172.0 lost
3 200.6 arrested
4 172.8 lost
5 218.0 lost
6 211.4 arrested
7 149.7 arrested
8 196.9 arrested
9 148.7 arrested
10 186.8 arrested
Table 4.11: Comparison of average nuclear cross-sectional area of GCs after exposure
to 0.2, 1 or 2 Gy of X-ray irradiations. The errors represent standard errors of the
means.
Proton radiation Mean nuclear cross-sectional area
dose (Gy) for giant cells (µm2)
0.2 172 ± 10
1 200 ± 20
2 181 ± 8
Figure 4.20 summarizes the fate of 40 individual giant-nucleated cells scored and
tracked alive in the progeny of irradiated AG1522 cells after exposure to 0.2, 1 or
2 Gy of X-ray irradiation. The plot shows the percentages of GCs that had either
lost or arrested during observation period at 7, 14 and 21 days of analysis post X-
ray irradiations. Some of arrested GCs may stay for longer times after irradiation
expressing a decrease in their nuclear cross-sectional area as appears in Figure 4.19
but without traversing more generations. This could be due to the overgrowth of
mitotic fibroblasts at these time points as reported for other fibroblast cell lines [105].
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The percentages recorded are based on the observations of the selected GCs, how-
ever, not necessary to represent the fate of other GCs that might be formed in the
irradiated populations.
Figure 4.20: Fate of giant-nucleated cells (GCs) selected after irradiating AG1522
normal-human diploid fibroblasts at various interval times (i.e. 7, 14 and 21 days)
when irradiated with 0.2, 1 or 2 Gy of X-ray irradiations.
The rate of lost events are more pronounced at all dose points than death or mitotic
arrest among all GCs followed at various observation times without an observation
of a single attempt of division.
Despite the time difference of GCs analysis (i.e. 7, 14 or 21 days), these results
confirm that the formation of GCs is still observed for up to 21 days post-irradiation.
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The results are in a good agreement with the observations of other authors using
the computerised video time lapse (CVTL) microscopy to determine the fate of the
HCT116, the human colorectal carcinoma cell line [88]. Therefore, the recurrent
induction of GCs in the samples that analysed 14 or 21 days post irradiation validates
that GCs could grow, differentiate and may divide to another GCs or normal-sized
cells. An alternative explanation for these results is that the GCs were directly
produced through endoreplication cycles as reported by [137].
The source of production of the new GCs in the following generation progeny is
still controversial. However, the potential source for such development might be from
a GC that managed successfully to escape death in early generations. Alternatively, it
could be from an X-irradiated semi-normal cell in a reproducible form that conceived
damage to next generation which then developed to give rise to newly GCs [212,222].
4.6.5.2 Fate of giant-nucleated cells produced by protons
In pilot experiments, the time-course of radiation-induced giant-nucleated using the
vertical beamline in the IBC, University of Surrey were also examined. The AG1522
normal fibroblast cells were exposed to average doses of proton beam irradiations
equivalent to those applied on populations irradiated with X-rays.
Following exposure to 0.2 Gy of protons, the progeny of 12 individual AG1522
giant-nucleated cells present 7, 14 and 21 days post irradiation were followed and
analysed from fluorescence images captured over the time of observation (Table 4.12).
The XY values for the field of view at which giant-cells identified were recorded
at the initial 24 hours of observation to identify their locations on the next day of
scanning. The parameters and settings of the microscope were fixed for the remaining
period of scan. Using the cell-recognition MATLAB code, the cross-sectional area for
each one of them was determined according to the criterion used for selecting GCs.
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Table 4.12: Fate of the giant-nucleated cells (GCs) followed in the progeny of AG1522
normal human-diploid fibroblast after exposure to 0.2 Gy of proton beam irradiation.
The horizontal lines represent the various interval times (i.e. 7, 14 and 21 days) of
sample preparations after irradiation.
Giant-nucleated Nuclear cross-sectional Ultimate
cells (GCs) area (µm2) fate
1 160.2 arrested
2 132.0 arrested
3 166.7 lost
4 169.2 arrested
5 158.2 lost
6 172.1 arrested
7 149.3 arrested
8 130.5 divided
9 223.5 arrested
10 163.9 arrested
11 225.2 lost
12 183.5 lost
All GCs were then tracked alive for a maximum period of 5 days until they were
either divide, arrested or lost out of the observation field. By the end of observation
period, 33% of the GCs had not been possible to follow to determine their fate might
be due to their migration and rapidly proliferation of surrounding normal cells.
High-LET protons are expected to decrease the enhancement of cell proliferation
as observed in other studies using carbon beam irradiations [220]. The explanation
for this results could refer to the non-homogeneity of the beam and possibility that
some of nuclei might be traversed by protons (i.e. one or more) where other were
not [29]. The other 59% of them could be followed to determine their fate and they
were either dead or arrested.
The remaining 8% of the GCs represented by a single giant cell (GC 8) from a
total of 12 giant-nucleated cells presented 14 days post-irradiation and maintained
alive to divided successfully to two asymmetrical daughter cells by the end of the
observation period (Figure 4.21).
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Figure 4.21: Fluorescence images of the giant-nucleated cell number eight formed in
the progeny of irradiated AG1522 populations. The cell presented at 14 days after
exposure with 0.2 Gy of proton beam irradiation. The nuclear cross-sectional area
of the cell was measured 24 hours post-incubation (first day of observation period)
using the cell-recognition MATLAB code and found to be 130.5 µm2. The division
was successfully completed 120 hours of the observation period. White circles to
recognise the descendants of the giant cell out of the other cells. The bar represents
10 µm.
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Its nuclear cross-sectional area was measured at the beginning of the observation
period and found to be 130.5 µm2. Although these two normal-sized cells were lost
due to normal process of cell migration which is thought to be enhanced by radiation
as reported by [220]. However, their rapid migration remain potential of having
progeny that would continue to proliferate. The ability of cell to migrate this way
in combination with additional features allow them to change their position within
tissues as usually observed in tumour invasion or metastases. Therefore, it is of
potential interest to consider such mechanisms which may cause crucial alterations
in cancer therapy treatments [223,224].
The average nuclear cross-sectional area for all GCs exposed to 0.2 Gy protons
was measured by 170 ± 9 µm2.
The AG1522 cells were also irradiated to 1 Gy of proton beam irradiation and
assayed for GCs analysis. A fraction of 12 GCs formed in the progeny of irradiated
AG1522 at 7, 14 and 21 days post-irradiation. The cells were identified at the be-
ginning of observation time for each time point and their nuclear cross-sectional area
were measured (Table 4.13). The maximum nuclear cross-sectional area was measured
for a giant cell number three (GC 3) and found to be 192.8 µm2. The the average for
the total of 12 GCs was measured by 156 ± 6 µm2.
The 75% of the GCs scored in the samples analysed at 7 and 14 days post-
irradiation was arrested. The majority of the either shrunken or wrinkled with a
higher rate of reproductive cell death which is a common feature for cells irradiated
to such dose as reported by [103]. On the other hand, it was difficult for the other
25% of GCs identified at 21 days after irradiation to be followed as they were lost
from the microscopy field. Note that those lost cells were rounded when they were
observed at beginning of the observation time as shown for GCs 10 and 12 (Figure
4.22). Thus, indicating that this the rounding process observed here could be related
to the mitotic activity which may lead in return to cell division as reported by [214].
118
Table 4.13: Fate of the giant-nucleated cells (GCs) have been followed in the progeny
of AG1522 normal human-diploid fibroblast after exposure to 1 Gy of proton beam
irradiation. Horizontal lines represent the interval times of 7, 14 and 21 days post-
irradiation.
Giant-nucleated Nuclear cross-sectional Ultimate
cells (GCs) area (µm2) fate
1 137.0 arrested
2 159.1 arrested
3 192.8 arrested
4 150.4 arrested
5 176.2 arrested
6 135.9 arrested
7 158.6 arrested
8 125.5 arrested
9 132.1 arrested
10 148.3 lost
11 172.9 lost
12 187.6 lost
Figure 4.22: Fluorescence images of the giant-nucleated cells 10 (left) and 12 (right)
identified at 21 days after exposure to 1 Gy of proton beam irradiation (Table 4.13).
Both cells were rounded and appeared mitotically active when they observed and be-
fore they were lost in the 24 hours of the observation time. The nuclear cross-sectional
area for both of them were measured by 148.3 µm2 and 187.6 µm2, respectively. White
bars represent 10 µm.
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The giant-nucleated cell number eleven (GC 11) was observed elongated which
may associated with the cytokinesis process that has been observed in general for
both control and irradiated cells (Figure 4.23). If the cell fails to remain arrested at
mitosis and adapt to the cytokinesis process. It is expected to produce two distinctly
giant cells as reported by [112]. The cell was lost out of the microscopy field when
the sample was scanned at 72 hours of the observation time.
Figure 4.23: Fluorescence images of the giant-nucleated cell number eleven (GCs 11;
see Table 4.13) after exposure to 1 Gy proton beam irradiation. The cell identified
at 21 days post irradiation. The cell was observed elongated at 24 hours (left) of
the observation time. The cell remained arrested for up to 48 hours (right) with a
potential attempt to undergo cytokinesis and divide. The nuclear cross-sectional area
was measured by 172.9 µm2 before it was lost at 72 hours of the observation time.
White bar is 10 µm.
These observations have confirmed that neither of the arrested nor the lost GCs
were succeed to divide at the time of observation in all samples analysed at the 7, 14
and 21 days after exposure to 1 Gy of proton beam irradiation.
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Finally, a few dishes were plated with low density of AG1522 cells, irradiated with
2 Gy of proton beam irradiation and incubated at 37◦C post-irradiation. As described
before, individual giant-nucleated cells were identified in each field and their presence
recorded on periodic examination (i.e. 7, 14 and 21 days after irradiation). A total
of 15 GCs were selected and followed to determine their fate during the observations
period (Table 4.14).
The maximum nuclear cross-sectional area for the scored GCs was measured for
the cell number 13 (GC 13) at 21 days post-irradiation and found to be 308 µm2
(Figure 4.24).
The average nuclear cross-sectional area of the GCs formed after exposure to
2 Gy of proton beam irradiation was measured by 175 ± 12 µm2. This value is
considered higher than those measured for the GCs formed in the progeny of 0.2 or
1 Gy populations (Table 4.15).
Table 4.14: Fate of the giant-nucleated cells (GCs) have been followed in the progeny
of AG1522 normal human-diploid fibroblast after exposure to 2 Gy of proton beam
irradiation
Giant-nucleated Nuclear cross-sectional Ultimate
cells (GCs) area (µm2) fate
1 176.4 lost
2 142.6 arrested
3 143.6 arrested
4 130.5 arrested
5 216.9 arrested
6 139.2 lost
7 201.2 arrested
8 153.8 arrested
9 190.4 arrested
10 153.5 arrested
11 184.0 arrested
12 137.3 arrested
13 308.0 arrested
14 142.3 lost
15 206.4 lost
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Figure 4.24: Fluorescence Hoechst 33258 images for the giant-nucleated cell number
13 formed in progeny of AG1522 cells after exposure to a dose of 2 Gy of proton beam
irradiation. The cell was presented at 21 days post-irradiation with a nuclear cross-
sectional area that measured by 308 µm2. The cells underwent a delay in the cell cycle
for the next 24 hours and remained arrested for almost 72 hours of the observation
period. The false threshold image produced by the cell-recognition MATLAB at 72
hours of the observation time shows the instability of the giant cell with deformity
features in common (finger-shaped) and a nuclear cross-sectional area measured by a
value of 204.1 µm2. The white circle to recognise the giant cell out of the other cells.
The white bar represents 10 µm.
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Table 4.15: Comparison of the average of nuclear cross-sectional area of GCs formed
after exposure to 0.2, 1 or 2 Gy of proton beam irradiations. Errors are standard
errors of the means.
Proton radiation Mean nuclear cross-sectional area
dose (Gy) for giant cells (µm2)
0.2 170 ± 9
1 156 ± 6
2 175 ± 12
The analysis of fluorescence microscopy images with the aid of cell-recognition
MATLAB code have shown that ∼ 73% of the GCs were undergone a transient delay
in their cell cycle that leads to mitotic or post-mitotic arrest and maintained for
couple of days. The fate of the remaining 27% of the total 15 individual GCs followed
was unknown because they were lost from the microscopy field between 24 snd 48
hours of the observation time. Figure 4.25 shows the comparison between the fate of
GCs that identified in the progeny of AG1522 cells following exposure to 0.2, 1 or 2
Gy of proton beam irradiations.
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Figure 4.25: Fate of GCs after exposure to 0.2, 1 or 2 Gy of X-ray irradiation. Figure
shows the percentage of GCs at each dose point when analysed at 7, 14 and 21 days
post-irradiation.
4.7 Summary
AG1522 cells were irradiated with 0.2-5 Gy of X-rays (2 keV/µm) and protons (12
keV/µm). It was found that no clear evidence of HRS in the proton survival curves,
which might describe the frequent induction of giant-nucleated cell as a function of
dose and LET. The temporary existence of the HRS phenomenon in the primary
results of the X ray survival curves might be a measure of radiation sensitivity in
the absence of fully active DNA damage repair (DDR) systems [225]. However, their
absence might also describe cell deformity and persistent induction of the mitotically
arrested GCs in the progeny of irradiated populations as reported by other authors
[49,192].
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The survival curves for both X-ray and proton irradiations were almost identi-
cal. However, the trend of the cell survival curve after protons was slightly steeper
compared to X-rays. Furthermore, the tail component which predominates at the
lower end of the curve around the dose of 5 Gy reflects the effect of the average dose
distribution of the proton beam irradiations.
The average cross-sectional areas of the giant- and normal-nucleated AG1522 cells
were measured as about 164.4 ± 1.5 µm2 and 36.5 ± 0.3 µm2, respectively.
Finally, the fate of 79 giant-nucleated cells induced in the progeny of X-ray (40
GCs) and proton (39 GCs) populations were determined and their status was classified
as divided, arrested or lost at the end of the observation period.
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Chapter 5
Summary and Conclusions
5.1 Overall conclusions and comments
The aim of this thesis is to determine whether in vitro normal human AG1522 fibrob-
last cells are susceptible to radiation-induced instability in terms of giant-nucleated
cell formation and, furthermore, to determine whether the GCs were persistent in the
progeny of irradiated cell populations when they were periodically subcultured and
allowed to proliferate for up to 21 days after X-ray irradiation. Another aim was to
determine the fate of selected fractions of GCs formed in the progeny of irradiated
populations at various interval times post-irradiation. This project also was designed
to compare the results of experiments that have been carried out using 250 kV X rays
and a vertical beamline with accelerated 3 MeV proton ions.
The delayed persistence of giant-nucleated cells (GCs) following exposure to 0.2, 1
and 2 Gy of X-ray or proton irradiation was determined in the progeny of normal hu-
man AG1522 fibroblast cell cultures. For these, nuclear DNA stains with fluorescence
microscopy were used to scan and image fixed or live giant-nucleated cells formed in
the progeny of irradiated populations at 7, 14 and 21 days post irradiation. A cell-
recognition MATLAB code was established to identify giant- and normal-nucleated
AG1522 cells and to measure their average cell nucleus cross-sectional areas.
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The average nuclear area for giant AG1522 cell was measured to be 164.4 ±
1.5 µm2. These values are in accordance with the values reported for the AG1522
cells and other cell lines and correlate well with different types of radiation. The
variations between the values for the nuclei areas reported in the literature appear
to depend on several parameters, such as type of cell line, the phase of the cells
during cell cycles and/or the status of the cells, i.e. whether they were fixed or
live. The nuclear area measured for the cells given such a set of parameters should be
considered as an indicative, rather than a definitive, endpoint, noting that it might not
be strictly valid for cells grown under different conditions. Moreover, the differences
in experimental methods, culture conditions or conditions for microscopic analysis
could be responsible for these variations.
The toxicity of the Hoechst 33258 dye used to stain the DNA in living AG1522
fibroblast cells was tested to evaluate its safety and efficiency with continuous imag-
ing and photobleaching in live cell experiments. The working concentration of the
Hoechst 33258 dye for live AG1522 cell fluorescence microscopy was measured at ap-
proximately 3 µg/ml (equivalent to 4.8 µM) to match the criteria of low toxicity,
phototoxicity and photobleaching [226]. A custom-made metallic slide with a 1 cm2
window in its centre, supported with a specifically designed plastic dish-holder, was
designed to immobilize the samples during scanning. This enhanced the ability to
focus sufficiently when scanning a large aerial region. In addition, the parameters
of the microscope were adjusted to limit the exposure time and the toxicity of the
ultraviolet light during the live cell scan. As support for this, a false threshold (black
and white) was applied using the cell-recognition MATLAB code to keep the scale of
intensity steady among the dishes examined for all experiments performed. The cells
were coloured and counted according to their nuclear areas.
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The results presented in this thesis confirm that the formation of GCs is persistent
and remains significant after 21 days (i.e. ∼24 population doublings) in the progeny of
X-irradiated populations when compared with the controls. This explanation is still
valid for the GCs present after 14 days in the progeny of the irradiated populations
following exposure to low doses of protons. The AG1522 cells have shown a dose-
dependent induction of GCs 7 days after proton irradiation, or up to 14 days after
X-irradiation. These observations are consistent with the notion of Roy et al. [211]
that radiation induced delayed giant-nucleated cell formation in a dose-dependent
manner.
The quantitative analysis of the digital images revealed that the yields of induction
of delayed GCs and their persistence in the X-irradiated survivors were greater than
those formed in the proton irradiated populations, particularly at low radiation doses.
The results confirm that the AG1522 cells are subject to a radiation-induced
increase in GCs formation at a dose of 1 Gy of X-ray irradiation. The yield of the
GCs was found to increase continually with time and was significantly greater (∼10%)
compared to those formed in proton irradiation.
Similar observations have been found for giant cells in the progeny of different
normal human fibroblasts after exposure to a single dose of 1 Gy of γ-rays [227].
However, the reduction in their formation 21 days post-exposure for both types of
irradiation might favour polyploid GCs formation, ultimately contributing to car-
cinogenesis, or radio- or chemotherapy resistance [16]. Puck et al. [9, 228] described
a similar formation in Hela cells following exposure to various doses of X-ray irradi-
ation. However, they noticed that, at a dose of ≥ 6 Gy X-rays, the ability of cells to
form progeny is highly reduced and the pronounced formation of GCs colonies in the
descendent populations is decreased.
128
This is consistent with the observations reported by Seymour et al. [229] for CHO-
K1 cells, as this reduction is thought to be associated with the decrease in their
colony-forming ability due to the detrimental effect of high doses of radiation and is
significantly persistent after ≥ 20 population doublings.
In parallel studies, the fate of a total of 79 individual giant-nucleated cells induced
in the progeny of X-ray or proton populations was determined. Their status was
classified as divided, arrested or lost at the end of the observation period. Our results
confirmed that a giant-nucleated cell that was formed at 14 days in the progeny of 0.2
Gy protons was successfully divided into asymmetric daughter cells. These results
are consistent with the notion of Prieur et al. [213], that a small fraction of giant cells
present after irradiation can divide several times. It should be noted that the GCs
formed in the progeny of irradiated populations after 0.2 Gy of protons have shown
a consistent and significant induction at 7, 14 and 21 days post-irradiation, when
compared with the controls. However, the persistent induction of such damage might
explain the discrepancy of the absence of low-dose HRS in the survival curves following
exposure to 0.2 Gy of proton beam irradiation, as hypothesized by Marples [50] and
others [191]. Such formation might alter the efficacy of radiation therapy when using
protons [107] or might contribute to the development of a second cancer risk [16].
The length of mitotic arrest for the other GCs was determined morphologically
using live fluorescence image microscopy, beginning when a cell first became giant
and ending when it shrank and flattened back onto the dish surface, or was lost when
it disappeared out of the observation field. After the XY values for GCs locations
were identified to allow for revisiting them throughout the observation period, the
cell-recognition MATLAB code was used immediately to confirm their cross-sectional
areas according to the criterion identified previously for selecting GCs.
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The results presented in this thesis confirm that giant AG1522 survivals exhibit
greater instability than GCs derived from controls following a dose-dependent be-
haviour. These observations are consistent with the notions of Prieur-Carrillo [213]
and Lyng et al. [89]. The persistent expression of such instability is correlated with
the genomic instability, the hallmark of cancer, as hypothesized by Wright and Lori-
more [217,218].
5.2 Future work and research directions
To summarize, the persistent expression of GCs and deformity highlighted in this
project are indicative of genetic instability, which needs to be considered during radi-
ation therapy treatment. Moreover, the absence of the HRS in the survival curves of
normal AG1522 cells after proton irradiation minimizes the possible advantage of the
use of such low-doses to improve the clinical outcomes, as recommended by Joiner
et al. [28]. The analysis of giant-nucleated cell formation at low-doses of protons
indicates that more of the healthy tissues might be at risk, which could have impor-
tant implications for human health and the radiation risk assessment of late effects
in radiotherapy applying heavy ions.
It should be noted that, for the first time, the vertical beamline facility at the
IBC, University of Surrey, Guildford, UK, was used to evaluate delayed effects (in
terms of GCs as an endpoint) in healthy (normal AG1522) tissues irradiated with
equivalent clinical doses of protons, comparing results with those obtained for X-ray
irradiation experiments. To the authors knowledge, there are no published data on
delayed persistence formation and potential fate of GCs at various interval times after
ionising radiation of in vitro replicating AG1522 cells, except for that presented in
this thesis [174].
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These data provide further insight into the radiobiological parameters, highlight-
ing the need for refinement of existing radiobiological parameters to incorporate such
effects and to modulate dose distributions. The findings of this research indicate that
the potential effect of low-doses of proton irradiation (i.e. at the end of the Bragg
region) needs to be properly administered to improve the treatment outcomes in pa-
tients instead of them developing a second cancer risk. These results also can act
as benchmark data for such work and might have important implications for studies
aimed at evaluating the efficacy of radiation therapy and in determining the risk of
delayed effects, particularly when applying protons.
Although the results achieved in this thesis, with the analysis of GCs formation
after X-ray and proton irradiation are promising, there are several important aspects
that remain to be clarified. Some of these aspects relate to the genotypic (i.e. chromo-
somal) alterations of the GCs and the potential formation of polyploidy or aneuploidy
cancer cells. Further research is needed to better investigate the chromosomal char-
acteristics of the persistent giant cells and their activation that display higher rates at
delayed time periods post-irradiation. The mitotic activity of GCs could be measured
by immunofluorescent detection of DSB induction and repair based on the counting
of γ-H2AX foci in response to ionising radiation.
In addition, the measurement taken of the area of giant cell nucleus (523.4 µm2)
formed after 4 Gy of proton beam irradiation could be an interesting area of study
to investigate the dose-relation response at radiation doses higher than those used in
this thesis (i.e. 0.2, 1 and 2 Gy).
Furthermore, to have a clearer picture of the differences between normal and
giant cells, the distribution of nuclear cross-sectional areas for normal- and giant-
sized AG1522 cells will be investigated for each dose point (for both X-ray and proton
irradiations) at various interval times.
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The average nuclear area for the sham-irradiated control AG1522 cells included
in this investigation will be ranged from 31 to 41 µm2 as measured before [174]. The
average starting measurement of the area of giant cell will be ≥ 125 µm2, which is
some four-folds greater than those formed in controls as was measured in this work
and identified in the literature [10].
Another area that needs to be covered in the near future is the loss of giant-
nucleated cells from the field of observation during live cell fluorescence microscopy,
which occurs because of their migration and the rapid proliferation of normal-nucleated
cells within the same fields.
The difficulty in monitoring GCs limits the current data and suggests that GCs
are much less proliferative than the controls. The use of time-lapse fluorescence mi-
croscopy will allow for the construction of cell guidance information during observa-
tion to overcome cell migration and the consequent loss of giant cells. This technique
will greatly expand the observations by also identifying the fate of daughter cells
produced by individual giant cells several generations post- irradiation. However, the
loss of GCs does not invalidate the conclusion that only a small fraction of them
could proliferate to form progeny that might be genomically unstable and resistant
to cancer therapy treatment.
Some developments have been made in the cell-recognition MATLAB code to
allow for counting the events of the DNA damage based on the number of γ-H2AX
foci following exposure to high doses of protons, which is the subject of a current
project1, since the current GCs analysis is based on the cell-recognition MATLAB
code method. Therefore, further developments to the code could benefit greatly the
measurement of other morphological alterations, such as micronuclei formation (MN).
It is also possible to measure the number of MN events in the same field as GCs and
to study the correlation of their formation with irradiation.
1Collaborative supervisor: Dr M. Merchant (University of Manchester, Manchester, UK).
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These data would be of great interest and would correlate well with the current
project, as their occurrence could be associated with the mitotic catastrophe or lack
of low-dose HRS, as observed in our results (e.g. see Figure 4.15), and is consistent
with the data available in the literature [192].
Future research could also consider using other normal human cell lines, or differ-
ent qualities of radiation with high- and low-doses of radiation (i.e. carbon ions or
alpha particles), to investigate the formation of GCs compared to the results obtained
in this thesis. This could include, in particular, the reproducibility of our successful
experiments using the new proton therapy facilities in the King Fahad Medical City
(Start of Treatment Plan, 2017) in collaboration with King Faisal Specialist Hospital
and Research Centre, Riyadh, Saudi Arabia or the Proton Therapy in the Christie
Centre, Manchester, UK (Start of Treatment Plan, 2018)2.
2Collaborative supervisor: Prof K. Kirby (University of Manchester, Manchester, UK).
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Publications and scientific
contributions
A. A. Almahwasi, J. C. Jeynes, D. A. Bradley and P. H. Regan, 2016. The
fate of radiation induced giant-nucleated cells of human skin fibroblasts.1
A. A. Almahwasi, J. C. Jeynes, M.J. Merchant, D.A. Bradley and P.H. Regan,
2016. Delayed persistence of giant-nucleated cells induced by X-ray and proton
irradiation in the progeny of replicating normal human fibroblast cells. Radiation
Physics and Chemistry Journal.2
A. A. Almahwasi, J.C. Jeynes, D. A. Bradley and P.H.Regan, 2016. Measure-
ments of frequent induction of giant-nucleated cells in the progeny of normal human
fibroblasts after exposure to low-energy proton beam irradiations in vitro. The In-
ternational Conference on Radiation Medicine (ICRM2016) at the King Faisal Hall,
The Intercontinental Hotel, and KFSHRC in Riyadh, Saudi Arabia3
A. A. Almahwasi, J.C. Jeynes, M.J. Merchant and K.J. Kirkby, 2013. The
Potential effects of low-doses of ionising radiation and malignancy. The 7th UK
and RI Postgraduate Conference in Biomedical Engineering and Medical Physics,
Guildford, Surrey, UK.University of Surrey; p41. ISBN: 978-1-84469-028-2.
1Submitted to Radiation Physics and Chemistry Journal.
2http://dx.doi.org/10.1016/j.radphyschem.2016.02.030.
3http://www.radmed.org/RB/Abstracts.pdf
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A. A. Almahwasi, J.C. Jeynes, M.J. Merchant and K.J. Kirkby, 2013. The Non-
targeted effects of low-doses of ionising radiation and potential risk of cancer. The
11th International Workshop on Microbeam Probes of Cellular Radiation Response,
Bordeaux, France. University of Bordeaux; p56.4
4http://www.cenbg.in2p3.fr/microbeam2013/pdf/2013MW-Abstract-booklet.pdf.
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